280 results on '"A. Aissaoui"'
Search Results
2. Focal splenic lesions: Imaging spectrum of diseases on CT, MRI and PET/CT
- Author
-
Christine Hoeffel, Anthony Dohan, Maxime Barat, Raphael Dautry, Amar Oudjit, Anita Paisant, Philippe Soyer, Brice Malgras, Mathilde Aissaoui, Anne-Ségolène Cottereau, Centre de Recherche en Sciences et Technologies de l'Information et de la Communication - EA 3804 (CRESTIC), and Université de Reims Champagne-Ardenne (URCA)
- Subjects
medicine.medical_specialty ,[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging ,Computed tomography ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Radiomics ,Artificial Intelligence ,Fluorodeoxyglucose F18 ,Positron Emission Tomography Computed Tomography ,Biopsy ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,ComputingMilieux_MISCELLANEOUS ,Splenic Diseases ,PET-CT ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,3. Good health ,Positron emission tomography ,Positron-Emission Tomography ,030220 oncology & carcinogenesis ,Radiology ,Splenic disease ,Degree of confidence ,Tomography, X-Ray Computed ,business - Abstract
The spleen can be affected by a variety of diseases. Some of them are readily identified as variations of normal or benign diseases on imaging. However, for a substantial number of focal splenic abnormalities, the diagnosis can be difficult so that histopathologic analysis may be required for a definite diagnosis. In this review, the typical splenic abnormalities that can be diagnosed with imaging with a high degree of confidence are illustrated. The complementary role of computed tomography (CT), magnetic resonance imaging and positron emission tomography/CT that helps make a diagnostic approach is discussed. Finally, current applications and future trends of radiomics and artificial intelligence for the diagnosis of splenic diseases are addressed.
- Published
- 2021
3. Prevalence of pressure injuries among critically ill patients and factors associated with their occurrence in the intensive care unit: The PRESSURE study
- Author
-
François Allaert, Laurent Poiroux, David Grimaldi, Nadia Aissaoui, Sabine Valera, Brigitte Barrois, Gaël Piton, Philippe Michel, Grégoire Muller, Gwenaëlle Jacq, Saber Barbar, David Huard, Atika Youssoufa, Guillaume Decormeille, Sami Hraiech, Florence Boissier, Paulo Ferreira, Florian Rigaudier, Nicholas Heming, and Jean-Baptiste Lascarrou
- Subjects
medicine.medical_specialty ,Critical Illness ,Beds ,Neurological disorder ,Emergency Nursing ,Critical Care Nursing ,Body weight ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,law ,Severity of illness ,Prevalence ,medicine ,Humans ,Multiple logistic regression analysis ,030212 general & internal medicine ,Simplified Acute Physiology Score ,Critically ill ,business.industry ,030208 emergency & critical care medicine ,medicine.disease ,Intensive care unit ,Confidence interval ,Intensive Care Units ,Emergency medicine ,business - Abstract
Background The prevalence of pressure injuries (PIs) in critically ill patients has been extensively studied, but there is uncertainty regarding the risk factors. The main objective of this study was to describe the prevalence of PIs in critically ill patients. Secondary objectives were to describe PI, use of preventive measures for PI, and factors associated with occurrence of PI in the intensive care unit (ICU). Material and methods This was a 1-day point-prevalence study performed on a weekday in June 2017 in ICUs in France. On the same day, we noted the presence or absence of PI in all hospitalised patients of the participating ICUs, data on the ICUs, and the characteristics of patients and of PI. Results Eighty-six participating ICUs allowed the inclusion of 1228 patients. The prevalence of PI on the study day was 18.7% (95% confidence interval: 16.6–21.0). PIs acquired in the ICU were observed in 12.5% (95% confidence interval: 10.6–14.3) of critically ill patients on the study day. The most frequent locations of PI were the sacrum (57.4%), heel (35.2%), and face (8.7%). Severe forms of PI accounted for 40.8% of all PIs. Antiulcer mattresses were used in 91.5% of the patients, and active and/or passive mobilisation was performed for all the patients. Multiple logistic regression analysis identified longer length of stay in the ICU, a higher Simplified Acute Physiology Score, higher body weight, motor neurological disorder, high-dose steroids, and absence of oral nutrition on the study day as factors independently associated with occurrence of PI in the ICU. Conclusion This large point-prevalence study shows that PIs are found in about one of five critically ill patients despite extensive use of devices for preventing PI. Acquisition of PI in the ICU is strongly related to the patient's severity of illness on admission to the ICU and length of stay in the ICU.
- Published
- 2021
4. Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI
- Author
-
Etienne Puymirat, Gilles Lemesle, Clément Delmas, Vincent Bataille, Frédéric Bouisset, Jean Ferrières, Didier Blanchard, Fast-Mi investigators, Francois Schiele, Pierre Coste, Nadia Aissaoui, Pascal Motreff, Guillaume Cayla, Edouard Gerbaud, Nicolas Danchin, Tabassome Simon, and Loic Belle
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,Myocardial revascularization ,Percutaneous ,medicine.medical_treatment ,Revascularization ,Time-to-Treatment ,Percutaneous Coronary Intervention ,Internal medicine ,Fibrinolysis ,medicine ,Humans ,Registries ,Myocardial infarction ,Aged ,business.industry ,Mortality rate ,Middle Aged ,medicine.disease ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,Observational study ,France ,Cardiology and Cardiovascular Medicine ,business - Abstract
The optimal management of patients with ST-segment elevation myocardial infarction (STEMI) presenting late-12 hours following symptom onset-is still under debate.The purpose of this study was to describe characteristics, temporal trends, and impact of revascularization in a large population of latecomer STEMI patients.The authors analyzed the data of 3 nationwide observational studies from the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) program, conducted over a 1-month period in 2005, 2010, and 2015. Patients presenting between 12 and 48 hours after symptom onset were classified as latecomers.A total of 6,273 STEMI patients were included in the 3 cohorts, 1,169 (18.6%) of whom were latecomers. After exclusion of patients treated with fibrinolysis and patients deceased within 2 days after admission, 1,077 patients were analyzed, of whom 729 (67.7%) were revascularized within 48 hours after hospital admission. At 30-day follow-up, all-cause death rate was significantly lower among revascularized latecomers (2.1% vs 7.2%; P 0.001). After a median follow-up of 58 months, the rate of all-cause death was 30.4 (95% CI: 25.7-35.9) per 1,000 patient-years in the revascularized latecomers group vs 78.7 (95% CI: 67.2-92.3) per 1,000 patient-years in the nonrevascularized latecomers group (P 0.001). In multivariate analysis, revascularization of latecomer STEMI patients was independently associated with a significant reduction of mortality occurrence during follow-up (HR: 0.65 [95% CI: 0.50-0.84]; P = 0.001).Coronary revascularization of latecomer STEMI patients is associated with better short and long-term clinical outcomes.
- Published
- 2021
5. Imported leishmaniasis in travelers: a 7-year retrospective from a Parisian hospital in France
- Author
-
Maud Gits-Muselli, Nesrine Aissaoui, Samia Hamane, Antoine Petit, Sarah Dellière, Stéphane Bretagne, Martine Bagot, Blandine Denis, Alexandre Alanio, Mazouz Benderdouche, Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Paris (UP), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Malbec, Odile, Université Paris Cité (UPCité), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
- Subjects
Leishmania tropica ,[SDV]Life Sciences [q-bio] ,030231 tropical medicine ,Leishmania guyanensis ,Leishmaniasis, Cutaneous ,Infectious and parasitic diseases ,RC109-216 ,Leishmania mexicana ,03 medical and health sciences ,Quantitative PCR ,0302 clinical medicine ,Cutaneous leishmaniasis ,parasitic diseases ,medicine ,Humans ,030212 general & internal medicine ,Leishmania infantum ,Leishmaniasis ,Retrospective Studies ,Leishmania major ,Visceral leishmaniasis ,biology ,business.industry ,Research ,biology.organism_classification ,medicine.disease ,Leishmania braziliensis ,Virology ,Hospitals ,3. Good health ,[SDV] Life Sciences [q-bio] ,Infectious Diseases ,Leishmaniasis, Visceral ,France ,Cytochrome b sequencing ,business - Abstract
Background Leishmaniases are regularly seen in non-endemic areas due to the increase of international travels. They include cutaneous leishmaniases (CL) and mucocutaneous (MC) caused by different Leishmania species, and visceral leishmaniases (VL) which present with non-specific symptoms. Methods We reviewed all consecutive leishmaniasis cases seen between September 2012 and May 2020. The diagnostic strategy included microscopy after May-Grünwald-Giemsa staining, a diagnostic quantitative PCR (qPCR) assay, and species identification based on sequencing of the cytochrome b gene. Results Eighty-nine patients had a definitive leishmaniasis diagnosis. Nine patients had VL with Leishmania infantum. Eighty patients had CL. Twelve patients acquired CL after trips in Latin America (7 Leishmania guyanensis, 2 Leishmania braziliensis, 2 Leishmania mexicana, and 1 Leishmania panamensis). Species could be identified in 63 of the 68 CLs mainly after travel in North Africa (59%) with Leishmania major (65%), Leishmania tropica/killicki (24%), and L. infantum (11%), or in West Sub-Saharan Africa (32%), all due to L. major. The median day between appearance of the lesions and diagnosis was 90 [range 60–127]. Conclusions Our diagnostic strategy allows both positive diagnoses and species identifications. Travelers in West Sub-Saharan Africa and North Africa should be better aware of the risk of contracting leishmananiasis., Highlights Imported leishmaniases are regularly seen in non-endemic areas.Cutaneous forms are due to different species that need to be correctly identified for adapting treatment and epidemiologic purposes.The index of suspicion for the visceral form is often low because of the non-specificity of the clinical symptoms and the notion of travel in endemic areas often remote.The strategy, based on diagnostic quantitative PCR followed by sequencing for species identification, allows for rapid and safe diagnoses in a routine laboratory.
- Published
- 2021
6. CT features of lung metastases from pancreatic adenocarcinoma: Correlation with histopathologic findings
- Author
-
Benoit Terris, Mathilde Aissaoui, Romain Coriat, Audrey Lupo, Guillaume Chassagnon, Marie-Pierre Revel, and Souhail Bennani
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Air bronchogram ,Adenocarcinoma ,Parenchyma ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Lung ,Halo sign ,Aged ,Retrospective Studies ,Aged, 80 and over ,Alveolar Wall ,Radiological and Ultrasound Technology ,business.industry ,Mean age ,General Medicine ,Middle Aged ,medicine.disease ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Alveolar Pattern ,Female ,medicine.symptom ,Tomography, X-Ray Computed ,business - Abstract
Purpose The purpose of this study was to evaluate the prevalence of an atypical, alveolar presentation of pulmonary metastases from pancreatic adenocarcinoma (PDAC) on computed tomography (CT) and to correlate CT features with those obtained at histopathologic analysis. Material and methods A total of 76 patients with lung metastases from PDAC over a 10-year period (2009–2019) in a French university hospital were retrospectively included. There were 34 men and 42 women with a mean age of 67.6 ± 11.3 (SD) years (range: 38–89 years). CT features of PDAC were classified according to their presentations as usual metastatic pattern or atypical alveolar pattern; the atypical alveolar pattern corresponding to either ground glass nodules or opacities, solid nodules with a halo sign, “air-space” nodules with air bronchogram, or parenchymal consolidation. Imaging-histopathologic correlation was performed when tissue samples were available. Results Pulmonary metastases were synchronous in 36 patients (36/76; 47%) and metachronous in 40 patients (40/76; 53%). A predominant alveolar presentation on CT was observed in 17 patients (17/76, 22%). Nodules with halo sign were the predominant alveolar pattern in 7 patients (7/17; 41%), air-space nodules were predominant in 4 patients (4/17; 24%) whereas pure ground glass nodules and consolidations were observed as predominant features in 3 patients (3/17; 18%) each. For 5 patients who had histopathological confirmation, alveolar metastases of PDAC were characterized by columnar tumor cells lining the alveolar wall, which was not seen in other radiological presentations, whereas there were no differences regarding mucin secretion between pulmonary metastases with alveolar presentation and those with typical pattern. Conclusions Lung metastases from PDAC may present with a so-called “alveolar” pattern on CT. This misleading CT features is found in 22% of patients with lung metastases from PDAC and is due to lepidic growth of the metastatic cells.
- Published
- 2021
7. Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
- Author
-
Houari Aissaoui, Kinan Drak Alsibai, and N. Khayath
- Subjects
Medicine (General) ,medicine.medical_specialty ,dermatomyositis ,Cyclophosphamide ,anti-MDA5 antibodies ,Case Report ,Disease ,polyarthritis ,030207 dermatology & venereal diseases ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,rapidly progressive interstitial pneumopathy ,medicine ,Medical history ,030203 arthritis & rheumatology ,Autoimmune disease ,business.industry ,Interstitial lung disease ,General Medicine ,Dermatomyositis ,medicine.disease ,Dermatology ,Polyarthritis ,Complication ,business ,medicine.drug - Abstract
Anti-MDA5 antibodies-associated amyopathic dermatomyositisis a rare autoimmune disease that involve polyarthritis, cutaneous and pulmonary manifestations. The development of rapidly progressing interstitial lung disease is a life-threatening complication. We report the case of a 45-year-old woman without medical history, who was addressed to the Pulmonary Department for a polyarthritis with dry cough and hypoxemic dyspnea. Initially there was neither cutaneous manifestation nor interstitial lung disease on chest CT scan. After a few days, the patient developed fatal acute respiratory failure with diffuse ground glass opacities. Identification of anti-MDA5 antibodies allowed establishing diagnosis, despite the fact that the first immunological assessment was negative. Corticosteroid bolus of 1 g for three days and immunosuppressive treatment by cyclophosphamide was only initiated at the acute respiratory distress syndrome stage. Given the rapidly unfavorable prognosis of this entity of amyopathic dermatomyositis, the testing for anti-MDA5 antibodies should be recommended in case of progressive pulmonary symptoms associated with joint signs in order to identify this disease at an early stage and to begin rapid and adequate management.
- Published
- 2021
8. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial
- Author
-
Nicolas de Prost, Saber Barbar, Stéphane Gaudry, Jean-Pierre Quenot, Christophe Vinsonneau, Laurent Argaud, Eric Boulet, Didier Thevenin, Didier Dreyfuss, Marion Beuzelin, Adrien Robine, Cyril Cadoz, Steven Grangé, Béatrice La Combe, Dimitri Titeca-Beauport, Julien Mayaux, Julio Badie, Saad Nseir, Guillaume Chevrel, Karim Asehnoune, Florent Poirson, Kada Klouche, Sébastien Moschietto, Guillaume Louis, Guillaume Thiery, Marc Leone, David Hajage, Pascal Andreu, Elisabeth Coupez, Bertrand Pons, Said Lebbah, Jean-Damien Ricard, Jean-Marie Forel, Laurent Martin-Lefevre, Julien Bohé, Guillaume Geri, Sébastien Besset, Karim Lakhal, Nicolas Chudeau, Alain Combes, Bertrand Rozec, Nadia Aissaoui, Guillaume Lacave, Jean Reignier, CarMeN, laboratoire, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), UFR Santé, Médecine et Biologie Humaine (UFR SMBH), Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre de Pharmacoépidémiologie de l'AP-HP (Cephepi), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Laboratoire Informatique, Image et Interaction - EA 2118 (L3I), La Rochelle Université (ULR), Centre Hospitalier Henri Duffaut (Avignon), CHU Amiens-Picardie, Université de Bretagne Sud - Lorient (UBS Lorient), Université de Bretagne Sud (UBS), Centre d'Etudes Lasers Intenses et Applications (CELIA), Université de Bordeaux (UB)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS), Hôpital Henri Mondor, Laboratoire Sciences Analytiques, Bioanalytiques, et Miniaturisation (LSABM), Chimie-Biologie-Innovation (UMR 8231) (CBI), Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier de Dieppe, CH Belfort-Montbéliard, Centre Hospitalier Sud Francilien, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Centre Hospitalier Le Mans (CH Le Mans), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Assistance Publique - Hôpitaux de Marseille (APHM), Centre Hospitalier de Lens, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Géomécanique, Matériaux et Structures (GEOMAS), Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service Anesthésie et Réanimation [Hôpital Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Centre Hospitalier de Versailles André Mignot (CHV), Centre d'Investigation Clinique - Innovation Technologique de Lille - CIC 1403 - CIC 9301 (CIC Lille), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital Ambroise Paré [AP-HP], Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre hospitalier régional Metz-Thionville (CHR Metz-Thionville), Service de Réanimation Médicale (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hôpital Louis Mourier - AP-HP [Colombes], Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Programme Hospitalier de Recherche Clinique., Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon, Université de La Rochelle (ULR), Département de Rhumatologie[Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie, Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Bordeaux (UB), Laboratoire de Tribologie et Dynamique des Systèmes (LTDS), École Centrale de Lyon (ECL), Université de Lyon-Université de Lyon-École Nationale des Travaux Publics de l'État (ENTPE)-Ecole Nationale d'Ingénieurs de Saint Etienne-Centre National de la Recherche Scientifique (CNRS), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), Centre Hospitalier Fleyriat [Bourg en Bresse], Centre Hospitalier Sud Francilien [Corbeil-Essonnes] (CH Sud Francilien), Centre Hospitalier de Béthune Beuvry (CH Béthune Beuvry), Hôpital Nord [CHU - APHM], GH Carnelle Portes de l'Oise, Hôpital Lapeyronie [Montpellier] (CHU), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord
- Subjects
medicine.medical_specialty ,MESH: Acute Kidney Injury ,[SDV]Life Sciences [q-bio] ,medicine.medical_treatment ,Population ,030204 cardiovascular system & hematology ,urologic and male genital diseases ,MESH: Severity of Illnes Index ,03 medical and health sciences ,MESH: Aged, 80 and over ,0302 clinical medicine ,Oliguria ,Intensive care ,Internal medicine ,Medicine ,MESH: Time-to-Treatment ,030212 general & internal medicine ,Renal replacement therapy ,education ,Blood urea nitrogen ,MESH: Aged ,education.field_of_study ,MESH: Humans ,MESH: Middle Aged ,business.industry ,Hazard ratio ,Acute kidney injury ,General Medicine ,medicine.disease ,MESH: Male ,MESH: Prospective Studies ,3. Good health ,[SDV] Life Sciences [q-bio] ,MESH: France ,MESH: Intensive Care Units ,medicine.symptom ,MESH: Renal Remplacement Therapy ,business ,MESH: Female ,Kidney disease - Abstract
International audience; BACKGROUND: Delaying renal replacement therapy (RRT) for some time in critically ill patients with severe acute kidney injury and no severe complication is safe and allows optimisation of the use of medical devices. Major uncertainty remains concerning the duration for which RRT can be postponed without risk. Our aim was to test the hypothesis that a more-delayed initiation strategy would result in more RRT-free days, compared with a delayed strategy. METHODS: This was an unmasked, multicentre, prospective, open-label, randomised, controlled trial done in 39 intensive care units in France. We monitored critically ill patients with severe acute kidney injury (defined as Kidney Disease: Improving Global Outcomes stage 3) until they had oliguria for more than 72 h or a blood urea nitrogen concentration higher than 112 mg/dL. Patients were then randomly assigned (1:1) to either a strategy (delayed strategy) in which RRT was started just after randomisation or to a more-delayed strategy. With the more-delayed strategy, RRT initiation was postponed until mandatory indication (noticeable hyperkalaemia or metabolic acidosis or pulmonary oedema) or until blood urea nitrogen concentration reached 140 mg/dL. The primary outcome was the number of days alive and free of RRT between randomisation and day 28 and was done in the intention-to-treat population. The study is registered with ClinicalTrial.gov, NCT03396757 and is completed. FINDINGS: Between May 7, 2018, and Oct 11, 2019, of 5336 patients assessed, 278 patients underwent randomisation; 137 were assigned to the delayed strategy and 141 to the more-delayed strategy. The number of complications potentially related to acute kidney injury or to RRT were similar between groups. The median number of RRT-free days was 12 days (IQR 0-25) in the delayed strategy and 10 days (IQR 0-24) in the more-delayed strategy (p=0·93). In a multivariable analysis, the hazard ratio for death at 60 days was 1·65 (95% CI 1·09-2·50, p=0·018) with the more-delayed versus the delayed strategy. The number of complications potentially related to acute kidney injury or renal replacement therapy did not differ between groups. INTERPRETATION: In severe acute kidney injury patients with oliguria for more than 72 h or blood urea nitrogen concentration higher than 112 mg/dL and no severe complication that would mandate immediate RRT, longer postponing of RRT initiation did not confer additional benefit and was associated with potential harm. FUNDING: Programme Hospitalier de Recherche Clinique.
- Published
- 2021
9. Survival and prognostic factors in adult medulloblastoma: the Salah Azaiz Institute experience
- Author
-
Lotfi Kochbati, S. Yahyaoui, R. Abidi, Alia Mousli, Asma Belaid, Chiraz Nasr, Dorra Aissaoui, and Amal Boussarsar
- Subjects
Medulloblastoma ,Oncology ,Chemotherapy ,medicine.medical_specialty ,Adult Medulloblastoma ,business.industry ,medicine.medical_treatment ,Malignant brain tumor ,General Medicine ,medicine.disease ,Radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Medulloblastoma is the most common malignant brain tumor in children. This entity in adulthood is rare. The aim of our study is to evaluate therapeutic results and prognostic factors of adult medulloblastoma treated at our institute with post-operative radiotherapy.We retrospectively reviewed a cohort of 55 patients with medulloblastoma who underwent radiation in the department of radiation oncology of institute Salah Azaiz (Tunis) over a 18-year period (1994-2012).The surgery was total or subtotal resection in 73% of cases. Forty-eight patients received radiotherapy to the entire craniospinal axis as part of the curative treatment. The median interval from surgery to the initiation of radiotherapy was 83 days. Etoposide-cisplatin chemotherapy was only performed in metastatic patients (Our results, compared to those of the literature, conclude that the reduction in the dose of radiotherapy to the craniospinal axis (34 Gy) in the standard risk group of adult medulloblastoma could not be done without chemotherapy. In the high-risk group of adult medulloblastoma, radiotherapy to the cerebrospinal axis at the dose of 36 Gy with chemotherapy, is required for disease control.
- Published
- 2021
10. A CASE OF TRAUMATIC NEUROMA OF THE COMMON BILIARY DUCT SIMULATING A CHOLANGIOCARCINOMA
- Author
-
Hajar Abdelouaheb, Mohammed Bouziane, Imane Kamaoui, Asmae Aissaoui, El. Mehdi Tiabi, Amal Bennani, Samia Malki, Younesse Najioui, Achraf Miry, Anas Haloui, and Ayoub Madani
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,medicine ,Radiology ,medicine.disease ,business ,digestive system ,Duct (anatomy) ,Traumatic neuroma - Abstract
We present a case of traumatic neuroma of the common bile duct in a 53-year-old woman who presented with jaundice,5months after cholecystectomy. Physical examination revealed jaundice, epigastric pain and scratching lesions. Gamma glutamyl transferase (GGT) at 109 U/L, Alkaline phosphatase at 175U/L. CA19-9 was at 500U/mlMagnetic resonance cholangiopancreatography revealed a T1 and T2hyperintense lesion of peri-hilar fat. An increase in intensity was noted after useof gadolinium.Exploratory laparotomy was performed with the presumptive diagnosis of cholangiocarcinoma. Pathologic analysis of the surgical specimen revealed Haphazard mature nerves, consistent with a bile duct neuroma. Follow-up of the patient showed no post-operative complications or signs of recurrence.
- Published
- 2021
11. Mastitis u deva u južnom Alžiru
- Author
-
Rachid Kaidi, Ratiba Baazizi, Mohamed Hocine Benaissa, Djamel Khelef, Messaouda Behalil, Fatma Zohra Aissaoui, Radhwane Saidi, and Nora Mimoune
- Subjects
Veterinary medicine ,General Veterinary ,business.industry ,medicine ,medicine.disease ,business ,Mastitis - Abstract
In Algeria, camel breeding participates in the national milk production. However, this breeding faces significant health problems, including mammary pathologies. This disease is a major public health threat, due to the existence of human pathogens in milk. Several species are associated with this mastitis. Unlike cow’s milk, goat and camel milk are most often consumed in the fresh raw state, thus escaping any official control. The present study aimed to determine the nature and frequency of mastitis, and the nature and frequency of the responsible bacteria in each type of mastitis in southern Algeria. A total of 62 camels were subjected to clinical examination and screening for subclinical mastitis and the presence of Brucella using the California Mastitis Test (CMT) and ring test, respectively. CMT positive samples were then further subjected to bacteriological analysis. Clinical and subclinical mastitis were present with frequencies of 4.44% and 95.55%, respectively. Bacteriological analysis isolated a total of 73 samples of 45 seeds. Staphylococci were most commonly isolated, with a frequency of 63.01%. Among these, Staphylococcus aureus were at the top of the list, with 35.61%, while Staphylococcus SCN (coagulase negative staphylococci) represented only 27.39%. Streptococci were the second most isolated group, with 28.77%. Gram-positive bacilli were in third place, accounting for 6.85% of all isolates. Gram- negative bacilli (enterobacteria) were isolated with a frequency of 1.36%. Brucella was present with a frequency of 4.44%. Finally, an extended study on a larger sample of camels is required in the future.
- Published
- 2021
12. Gender imbalance in intensive care: High time for action and evaluation!
- Author
-
Hauw-Berlemont, Caroline, Salmon Gandonnière, Charlotte, Boissier, Florence, Aissaoui, Nadia, Bodet-Contentin, Laetitia, Fartoukh, Muriel, Jourdain, Mercedes, Le Marec, Julien, Tamion, Fabienne, Hamzaoui, Olfa, Aubron, Cécile, Group For The French Intensive Care Society, The Femmir (femme Médecins En Médecine Intensive Réanimation), Gestionnaire, Hal Sorbonne Université, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre d’Investigation Clinique [Tours] CIC 1415 (CIC ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre hospitalier universitaire de Poitiers (CHU Poitiers), CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN), CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Lille, Recherche translationnelle sur le diabète - U 1190 (RTD), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de Pneumologie et Réanimation Médicale [CHU Pitié-Salpêtrière] (Département ' R3S '), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Neurophysiologie Respiratoire Expérimentale et Clinique (UMRS 1158), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU), Endothélium, valvulopathies et insuffisance cardiaque (EnVI), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Bretagne Occidentale - UFR Médecine et Sciences de la Santé (UBO UFR MSS), Université de Brest (UBO), The FEMMIR (Femme Médecins en Médecine Intensive Réanimation) Group for the French Intensive Care Society : Caroline Hauw-Berlemont, Charlotte Salmon Gandonnière, Florence Boissier, Nadia Aissaoui, Laetitia Bodet-Contentin, Muriel Sarah Fartoukh, Mercedes Jourdain, Julien Le Marec, Fabienne Tamion, Olfa Hamzaoui & Cécile Aubron, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Neurophysiologie Respiratoire Expérimentale et Clinique, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
- Subjects
Critical Care ,business.industry ,RC86-88.9 ,[SDV]Life Sciences [q-bio] ,Research ,Sexism ,MEDLINE ,030208 emergency & critical care medicine ,Medical emergencies. Critical care. Intensive care. First aid ,Critical Care and Intensive Care Medicine ,medicine.disease ,[SDV] Life Sciences [q-bio] ,03 medical and health sciences ,0302 clinical medicine ,Editorial ,030228 respiratory system ,Action (philosophy) ,Intensive care ,Medicine ,Humans ,Medical emergency ,business ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2021
13. Sepsis at ICU admission does not decrease 30-day survival in very old patients : a post-hoc analysis of the VIP1 multinational cohort study
- Author
-
Ibarz, Mercedes, Boumendil, Ariane, Haas, Lenneke E M, Irazabal, Marian, Flaatten, Hans, de Lange, Dylan W, Morandi, Alessandro, Andersen, Finn H, Bertolini, Guido, Cecconi, Maurizio, Christensen, Steffen, Faraldi, Loredana, Fjølner, Jesper, Jung, Christian, Marsh, Brian, Moreno, Rui, Oeyen, Sandra, Öhman, Christina Agwald, Bollen Pinto, Bernardo, Soliman, Ivo W, Szczeklik, Wojciech, Valentin, Andreas, Watson, Ximena, Zaferidis, Tilemachos, Guidet, Bertrand, Artigas, Antonio, Schmutz R, Wimmer F, Eller P, Joannidis M, De Buysscher P, De Neve N, Oeyen S, Swinnen W, Bollen Pinto B, Abraham P, Hergafi L, Schefold JC, Biskup E, Piza P, Taliadoros I, Fjølner J, Dey N, Sølling C, Rasmussen BS, Christensen S, Forceville X, Besch G, Mentec H, Michel P, Mateu P, Vettoretti L, Bourenne J, Marin N, Guillot M, Aissaoui N, Goulenok C, Thieulot-Rolin N, Messika J, Lamhaut L, Guidet B, Charron C, Lauten A, Sacher AL, Brenner T, Franz M, Bloos F, Ebelt H, Schaller SJ, Fuest K, Rabe C, Dieck T, Steiner S, Graf T, Nia AM, Jung C, Janosi RA, Meybohm P, Simon P, Utzolino S, Rahmel T, Barth E, Schuster M, Aidoni Z, Aloizos S, Tasioudis P, Lampiri K, Zisopoulou V, Ravani I, Pagaki E, Antoniou A, Katsoulas TA, Kounougeri A, Marinakis G, Tsimpoukas F, Spyropoulou A, Zygoulis P, Kyparissi A, Gupta M, Gurjar M, Maji IM, Hayes I, Marsh B, Kelly Y, Westbrook A, Fitzpatrick G, Maheshwari D, Motherway C, Negri G, Spadaro S, Nattino G, Pedeferri M, Boscolo A, Rossi S, Calicchio G, Cubattoli L, Di Lascio G, Barbagallo M, Berruto F, Codazzi D, Bottazzi A, Fumagalli P, Negro G, Lupi G, Savelli F, Vulcano GA, Fumagalli R, Marudi A, Lefons U, Lembo R, Babini M, Paggioro A, Parrini V, Zaccaria M, Clementi S, Gigliuto C, Facondini F, Pastorini S, Munaron S, Calamai I, Bocchi A, Adorni A, Bocci MG, Cortegiani A, Casalicchio T, Melia S, Graziani E, Barattini M, Brizio E, Rossi M, Hahn M, Flattens H, Kemmerer N, Streiter HF, Dybwik K, Legernaes T, Klepstad P, Olaussen EB, Olsen KI, Brresen OM, Bjorsvik G, Andersen FH, Maini S, Fehrle L, Czuczwar M, Krawczyk P, Ziętkiewicz M, Nowak ŁR, Kotfis K, Cwyl K, Gajdosz R, Biernawska J, Bohatyrewicz R, Gawda R, Grudzień P, Nasiłowski P, Popek N, Cyrankiewicz W, Wawrzyniak K, Wnuk M, Maciejewski D, Studzińska D, Żukowski M, Bernas S, Piechota M, Szczeklik W, Nowak-Kózka I, Fronczek J, Serwa M, Machała W, Stefaniak J, Wujtewicz M, Szymkowiak M, Adamik B, Polok K, Włudarczyk A, Górka J, Kozera N, Goździk W, Catorze N, Branco MC, Barros I, Barros N, Krystopchuk A, Honrado T, Sousa C, Munoz F, Rebelo M, Gomes R, Nunes J, Dias C, Fernandes AM, Petrisor C, Constantin B, Belskiy V, Boskholov B, Rodriguez E, Rebollo S, Aguilar G, Masdeu G, Jaimes MI, Mira ÁP, Bodi MA, Barea Mendoza JA, López-Cuenca S, Guzman MH, Rico-Feijoo J, Ibarz M, Alvarez JT, Kawati R, Sivik J, Nauska J, Smole D, Parenmark F, Lyrén J, Rockstrohm K, Rydén S, Spångfors M, Strinnholm M, Walther S, De Geer L, Nordlund P, Pålsson S, Zetterquist H, Nilsson A, Thiringer K, Jungner M, Bark B, Nordling B, Sköld H, Brorsson C, Persson S, Bergström A, Berkius J, Holmström J, van Dijk I, Haas LEM, Ramnarain D, Jansen T, Nooteboom F, van der Voort PHJ, de Lange D, Dieperink W, de Waard MC, de Smet AGE, Bormans L, Dormans T, Dempsey G, Mathew SJ, Raj AS, Grecu I, Cupitt J, Lawton T, Clark R, Popescu M, Spittle N, Faulkner M, Cowton A, Elloway E, Williams P, Reay M, Chukkambotla S, Kumar R, Al-Subaie N, Kent L, Tamm T, Kajtor I, Burns K, Pugh R, Ostermann M, Kam E, Bowyer H, Smith N, Templeton M, Henning J, Goffin K, Kapoor R, Laha S, Chilton P, Khaliq W, Crayford A, Coetzee S, Tait M, Stoker W, Gimenez M, Pope A, Camsooksai J, Pogson D, Quigley K, Ritzema J, Hormis A, Boulanger C, Balasubramaniam M, Vamplew L, Burt K, Martin D, Craig J, Prowle J, Doyle N, Shelton J, Scott C, Donnison P, Shelton S, Frey C, Ryan C, Spray D, Barnes V, Barnes K, Ridgway S, Saha R, Clark T, Wood J, Bolger C, Bassford C, Lewandowski J, Zhao X, Humphreys S, Dowling S, Richardson N, Burtenshaw A, Stevenson C, Wilcock D, Nalapko Y., Ibarz, M, Boumendil, A, Haas, L, Irazabal, M, Flaatten, H, de Lange, D, Morandi, A, Andersen, F, Bertolini, G, Cecconi, M, Christensen, S, Faraldi, L, Fjolner, J, Jung, C, Marsh, B, Moreno, R, Oeyen, S, Ohman, C, Bollen Pinto, B, Soliman, I, Szczeklik, W, Valentin, A, Watson, X, Zaferidis, T, Guidet, B, Artigas, A, Schmutz, R, Wimmer, F, Eller, P, Joannidis, M, De Buysscher, P, De Neve, N, Swinnen, W, Abraham, P, Hergafi, L, Schefold, J, Biskup, E, Piza, P, Taliadoros, I, Dey, N, Solling, C, Rasmussen, B, Forceville, X, Besch, G, Mentec, H, Michel, P, Mateu, P, Vettoretti, L, Bourenne, J, Marin, N, Guillot, M, Aissaoui, N, Goulenok, C, Thieulot-Rolin, N, Messika, J, Lamhaut, L, Charron, C, Lauten, A, Sacher, A, Brenner, T, Franz, M, Bloos, F, Ebelt, H, Schaller, S, Fuest, K, Rabe, C, Dieck, T, Steiner, S, Graf, T, Nia, A, Janosi, R, Meybohm, P, Simon, P, Utzolino, S, Rahmel, T, Barth, E, Schuster, M, Aidoni, Z, Aloizos, S, Tasioudis, P, Lampiri, K, Zisopoulou, V, Ravani, I, Pagaki, E, Antoniou, A, Katsoulas, T, Kounougeri, A, Marinakis, G, Tsimpoukas, F, Spyropoulou, A, Zygoulis, P, Kyparissi, A, Gupta, M, Gurjar, M, Maji, I, Hayes, I, Kelly, Y, Westbrook, A, Fitzpatrick, G, Maheshwari, D, Motherway, C, Negri, G, Spadaro, S, Nattino, G, Pedeferri, M, Boscolo, A, Rossi, S, Calicchio, G, Cubattoli, L, Di Lascio, G, Barbagallo, M, Berruto, F, Codazzi, D, Bottazzi, A, Fumagalli, P, Negro, G, Lupi, G, Savelli, F, Vulcano, G, Fumagalli, R, Marudi, A, Lefons, U, Lembo, R, Babini, M, Paggioro, A, Parrini, V, Zaccaria, M, Clementi, S, Gigliuto, C, Facondini, F, Pastorini, S, Munaron, S, Calamai, I, Bocchi, A, Adorni, A, Bocci, M, Cortegiani, A, Casalicchio, T, Melia, S, Graziani, E, Barattini, M, Brizio, E, Rossi, M, Hahn, M, Flattens, H, Kemmerer, N, Streiter, H, Dybwik, K, Legernaes, T, Klepstad, P, Olaussen, E, Olsen, K, Brresen, O, Bjorsvik, G, Maini, S, Fehrle, L, Krawczyk, P, Zietkiewicz, M, Nowak, L, Kotfis, K, Cwyl, K, Gajdosz, R, Biernawska, J, Bohatyrewicz, R, Gawda, R, Grudzien, P, Nasilowski, P, Popek, N, Cyrankiewicz, W, Wawrzyniak, K, Wnuk, M, Maciejewski, D, Studzinska, D, Zukowski, M, Bernas, S, Piechota, M, Nowak-Kozka, I, Fronczek, J, Serwa, M, Stefaniak, J, Wujtewicz, M, Szymkowiak, M, Adamik, B, Polok, K, Wludarczyk, A, Gorka, J, Kozera, N, Gozdzik, W, Catorze, N, Branco, M, Barros, I, Barros, N, Krystopchuk, A, Honrado, T, Sousa, C, Munoz, F, Rebelo, M, Gomes, R, Nunes, J, Dias, C, Fernandes, A, Petrisor, C, Constantin, B, Belskiy, V, Boskholov, B, Rodriguez, E, Rebollo, S, Aguilar, G, Masdeu, G, Jaimes, M, Mira, A, Bodi, M, Barea Mendoza, J, Lopez-Cuenca, S, Guzman, M, Rico-Feijoo, J, Alvarez, J, Kawati, R, Sivik, J, Nauska, J, Parenmark, F, Lyren, J, Rockstrohm, K, Ryden, S, Spangfors, M, Strinnholm, M, Walther, S, De Geer, L, Nordlund, P, Palsson, S, Zetterquist, H, Nilsson, A, Thiringer, K, Jungner, M, Bark, B, Nordling, B, Skold, H, Brorsson, C, Persson, S, Bergstrom, A, Berkius, J, Holmstrom, J, van Dijk, I, Ramnarain, D, Jansen, T, Nooteboom, F, van der Voort, P, Dieperink, W, de Waard, M, de Smet, A, Bormans, L, Dormans, T, Dempsey, G, Mathew, S, Raj, A, Grecu, I, Cupitt, J, Lawton, T, Clark, R, Popescu, M, Spittle, N, Faulkner, M, Cowton, A, Elloway, E, Williams, P, Reay, M, Chukkambotla, S, Kumar, R, Al-Subaie, N, Kent, L, Tamm, T, Kajtor, I, Burns, K, Pugh, R, Ostermann, M, Kam, E, Bowyer, H, Smith, N, Templeton, M, Henning, J, Goffin, K, Kapoor, R, Laha, S, Chilton, P, Khaliq, W, Crayford, A, Coetzee, S, Tait, M, Stoker, W, Gimenez, M, Pope, A, Camsooksai, J, Pogson, D, Quigley, K, Ritzema, J, Hormis, A, Boulanger, C, Balasubramaniam, M, Vamplew, L, Burt, K, Martin, D, Craig, J, Prowle, J, Doyle, N, Shelton, J, Scott, C, Donnison, P, Shelton, S, Frey, C, Ryan, C, Spray, D, Barnes, V, Barnes, K, Ridgway, S, Saha, R, Clark, T, Wood, J, Bolger, C, Bassford, C, Lewandowski, J, Zhao, X, Humphreys, S, Dowling, S, Richardson, N, Burtenshaw, A, Stevenson, C, Wilcock, D, Nalapko, Y, Ibarz, Mercede, Boumendil, Ariane, Haas, Lenneke E M, Irazabal, Marian, Flaatten, Han, de Lange, Dylan W, Morandi, Alessandro, Andersen, Finn H, Bertolini, Guido, Cecconi, Maurizio, Christensen, Steffen, Faraldi, Loredana, Fjølner, Jesper, Jung, Christian, Marsh, Brian, Moreno, Rui, Oeyen, Sandra, Öhman, Christina Agwald, Bollen Pinto, Bernardo, Soliman, Ivo W, Szczeklik, Wojciech, Valentin, Andrea, Watson, Ximena, Zaferidis, Tilemacho, Guidet, Bertrand, Artigas, Antonio, Schmutz R, Wimmer F, Eller P, Joannidis M, De Buysscher P, De Neve N, Oeyen S, Swinnen W, Bollen Pinto B, Abraham P, Hergafi L, Schefold JC, Biskup E, Piza P, Taliadoros I, Fjølner J, Dey N, Sølling C, Rasmussen BS, Christensen S, Forceville X, Besch G, Mentec H, Michel P, Mateu P, Michel P, Vettoretti L, Bourenne J, Marin N, Guillot M, Aissaoui N, Goulenok C, Thieulot-Rolin N, Messika J, Lamhaut L, Guidet B, Charron C, Lauten A, Sacher AL, Brenner T, Franz M, Bloos F, Ebelt H, Schaller SJ, Fuest K, Rabe C, Dieck T, Steiner S, Graf T, Nia AM, Jung C, Janosi RA, Meybohm P, Simon P, Utzolino S, Rahmel T, Barth E, Jung C, Schuster M, Aidoni Z, Aloizos S, Tasioudis P, Lampiri K, Zisopoulou V, Ravani I, Pagaki E, Antoniou A, Katsoulas TA, Kounougeri A, Marinakis G, Tsimpoukas F, Spyropoulou A, Zygoulis P, Kyparissi A, Gupta M, Gurjar M, Maji IM, Hayes I, Marsh B, Kelly Y, Westbrook A, Fitzpatrick G, Maheshwari D, Motherway C, Negri G, Spadaro S, Nattino G, Pedeferri M, Boscolo A, Rossi S, Calicchio G, Cubattoli L, Di Lascio G, Barbagallo M, Berruto F, Codazzi D, Bottazzi A, Fumagalli P, Negro G, Lupi G, Savelli F, Vulcano GA, Fumagalli R, Marudi A, Lefons U, Lembo R, Babini M, Paggioro A, Parrini V, Zaccaria M, Clementi S, Gigliuto C, Facondini F, Pastorini S, Munaron S, Calamai I, Bocchi A, Adorni A, Bocci MG, Cortegiani A, Casalicchio T, Melia S, Graziani E, Barattini M, Brizio E, Rossi M, Hahn M, Flattens H, Kemmerer N, Streiter HF, Dybwik K, Legernaes T, Klepstad P, Olaussen EB, Olsen KI, Brresen OM, Bjorsvik G, Andersen FH, Maini S, Fehrle L, Czuczwar M, Krawczyk P, Ziętkiewicz M, Nowak ŁR, Kotfis K, Cwyl K, Gajdosz R, Biernawska J, Bohatyrewicz R, Gawda R, Grudzień P, Nasiłowski P, Popek N, Cyrankiewicz W, Wawrzyniak K, Wnuk M, Maciejewski D, Studzińska D, Żukowski M, Bernas S, Piechota M, Szczeklik W, Nowak-Kózka I, Fronczek J, Serwa M, Machała W, Stefaniak J, Wujtewicz M, Szymkowiak M, Adamik B, Polok K, Włudarczyk A, Górka J, Kozera N, Goździk W, Catorze N, Branco MC, Barros I, Barros N, Krystopchuk A, Honrado T, Sousa C, Munoz F, Rebelo M, Gomes R, Nunes J, Dias C, Fernandes AM, Petrisor C, Constantin B, Belskiy V, Boskholov B, Rodriguez E, Rebollo S, Aguilar G, Masdeu G, Jaimes MI, Mira ÁP, Bodi MA, Barea Mendoza JA, López-Cuenca S, Guzman MH, Rico-Feijoo J, Ibarz M, Alvarez JT, Kawati R, Sivik J, Nauska J, Smole D, Parenmark F, Lyrén J, Rockstrohm K, Rydén S, Spångfors M, Strinnholm M, Walther S, De Geer L, Nordlund P, Pålsson S, Zetterquist H, Nilsson A, Thiringer K, Jungner M, Bark B, Nordling B, Sköld H, Brorsson C, Persson S, Bergström A, Berkius J, Holmström J, van Dijk I, Haas LEM, Ramnarain D, Jansen T, Nooteboom F, van der Voort PHJ, de Lange D, Dieperink W, de Waard MC, de Smet AGE, Bormans L, Dormans T, Dempsey G, Mathew SJ, Raj AS, Grecu I, Cupitt J, Lawton T, Clark R, Popescu M, Spittle N, Faulkner M, Cowton A, Elloway E, Williams P, Reay M, Chukkambotla S, Kumar R, Al-Subaie N, Kent L, Tamm T, Kajtor I, Burns K, Pugh R, Ostermann M, Kam E, Bowyer H, Smith N, Templeton M, Henning J, Goffin K, Kapoor R, Laha S, Chilton P, Khaliq W, Crayford A, Coetzee S, Tait M, Stoker W, Gimenez M, Pope A, Camsooksai J, Pogson D, Quigley K, Ritzema J, Hormis A, Boulanger C, Balasubramaniam M, Vamplew L, Burt K, Martin D, Grecu I, Craig J, Prowle J, Doyle N, Shelton J, Scott C, Donnison P, Shelton S, Frey C, Ryan C, Spray D, Ryan C, Barnes V, Barnes K, Ridgway S, Saha R, Kent L, Clark T, Wood J, Bolger C, Bassford C, Cowton A, Lewandowski J, Zhao X, Humphreys S, Dowling S, Richardson N, Burtenshaw A, Stevenson C, Wilcock D, Nalapko Y., Critical Care, and Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
- Subjects
INTENSIVE-CARE-UNIT ,Survival ,HSJ UCI ,Critical Care and Intensive Care Medicine ,survival analysis ,law.invention ,sepsis ,Severity of illne ,0302 clinical medicine ,LONG-TERM OUTCOMES ,overlevingsanalyse ,law ,Medicine and Health Sciences ,EPIDEMIOLOGY ,Intensive care ,Mortality ,Outcome ,Sepsis ,Severity of illness ,Very old ,030212 general & internal medicine ,Prospective cohort study ,ELDERLY-PATIENTS ,ddc:617 ,PATIENTS AGED 80 ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,Very Old ,Intensive care unit ,SOFA score ,medicine.symptom ,CRITICALLY-ILL PATIENTS ,WITHDRAWAL ,hormones, hormone substitutes, and hormone antagonists ,medicine.medical_specialty ,Sepsi ,elderly patients ,NO ,03 medical and health sciences ,sterfte ,Internal medicine ,medicine ,FRAILTY ,business.industry ,Septic shock ,Research ,SEPTIC SHOCK ,Organ dysfunction ,Intensive Care ,030208 emergency & critical care medicine ,lcsh:RC86-88.9 ,oudere patiënten ,medicine.disease ,business - Abstract
BackgroundThe number of intensive care patients aged ≥ 80 years (Very old Intensive Care Patients; VIPs) is growing. VIPs have high mortality and morbidity and the benefits of ICU admission are frequently questioned. Sepsis incidence has risen in recent years and identification of outcomes is of considerable public importance. We aimed to determine whether VIPs admitted for sepsis had different outcomes than those admitted for other acute reasons and identify potential prognostic factors for 30-day survival.ResultsThis prospective study included VIPs with Sequential Organ Failure Assessment (SOFA) scores ≥ 2 acutely admitted to 307 ICUs in 21 European countries. Of 3869 acutely admitted VIPs, 493 (12.7%) [53.8% male, median age 83 (81–86) years] were admitted for sepsis. Sepsis was defined according to clinical criteria; suspected or demonstrated focus of infection and SOFA score ≥ 2 points. Compared to VIPs admitted for other acute reasons, VIPs admitted for sepsis were younger, had a higher SOFA score (9 vs. 7,p p p p = 0.02]. Frailty was similar in both groups. Unadjusted 30-day survival was not significantly different between the two groups. After adjustment for age, gender, frailty, and SOFA score, sepsis had no impact on 30-day survival [HR 0.99 (95% CI 0.86–1.15),p = 0.917]. Inverse-probability weight (IPW)-adjusted survival curves for the first 30 days after ICU admission were similar for acute septic and non-septic patients [HR: 1.00 (95% CI 0.87–1.17),p = 0.95]. A matched-pair analysis in which patients with sepsis were matched with two control patients of the same gender with the same age, SOFA score, and level of frailty was also performed. A Cox proportional hazard regression model stratified on the matched pairs showed that 30-day survival was similar in both groups [57.2% (95% CI 52.7–60.7) vs. 57.1% (95% CI 53.7–60.1),p = 0.85].ConclusionsAfter adjusting for organ dysfunction, sepsis at admission was not independently associated with decreased 30-day survival in this multinational study of 3869 VIPs. Age, frailty, and SOFA score were independently associated with survival.
- Published
- 2020
14. Hydroxyzine revealing acquired neuromuscular weakness in a patient with COVID-19 disease
- Author
-
Younes Aissaoui, Youssef Qamouss, Ayoub Belhadj, Mohamed Bahi, and Rachid Seddiki
- Subjects
Hydroxyzine ,ARDS ,Coronavirus disease 2019 (COVID-19) ,business.industry ,medicine.medical_treatment ,Disease ,medicine.disease ,Anesthesia ,medicine ,Antihistamine ,medicine.symptom ,Respiratory system ,business ,Hypercapnia ,Neuromuscular Manifestations ,medicine.drug - Abstract
Acquired neuromuscular weakness often develops in patients with an acute respiratory distress syndrome (ARDS), in particular in patients who are ventilated and sedated for long periods. This has been rarely described in the literature on ARDS secondary to SARS-CoV-2 infection. Our clinical case revealed the existence of these neuromuscular manifestations in the COVID-19 disease after the use of hydroxyzine, an antihistamine whose respiratory side-effects are unknown. Keywords: Neuromuscular weakness, COVID-19, hydroxyzine, hypercapnia.
- Published
- 2021
15. Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
- Author
-
David Grimaldi, Nadia Aissaoui, Gauthier Blonz, Giuseppe Carbutti, Romain Courcelle, Stephane Gaudry, Aurelie Gaultier, Alain D’hondt, Julien Higny, Geoffrey Horlait, Sami Hraiech, Laurent Lefebvre, Francois Lejeune, Andre Ly, Michael Piagnerelli, Bertrand Sauneuf, Nicolas Serck, Thibaud Soumagne, Piotr Szychowiak, Julien Textoris, Benoit Vandenbunder, Christophe Vinsonneau, Jean- Baptiste Lascarrou, for the COVADIS study group, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Services des soins intensifs, Hôpital Erasme [Bruxelles] (ULB), Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre Hospitalier Départemental site de la Roche-sur-Yon (CHD de la Roche-sur-Yon), hospital universitaire de Mons-Hainaut, Hopital de Jolimont, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Plateforme de Méthodologie et Biostatistique, Direction de la Recherche [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Ambroise Paré [Mons, Belgium], CHU Dinant-Godinne UCL Namur [Yvoir, Belgique], Hôpital Nord [CHU - APHM], Centre d'études et de recherche sur les services de santé et la qualité de vie (CEReSS), Aix Marseille Université (AMU), Centre Hospitalier du Pays d'Aix, Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université libre de Bruxelles (ULB), Grand Hôpital de Charleroi [Belgium], Service de Réanimation Polyvalente [CHPC - Site Louis Pasteur], Site Louis Pasteur [CHPC], CH Centre Hospitalier Public du Cotentin (CHPC)-CH Centre Hospitalier Public du Cotentin (CHPC), Saint Pierre clinic of Ottignies (CSPO), Saint Pierre clinic of Ottignies, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service de Médecine Intensive et Réanimation [Tours], Centre d’Investigation Clinique [Tours] CIC 1415 (CIC ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Réseau CRICS-TRIGGERSEP [CHRU Tours] (F-CRIN research network), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Hospices Civils de Lyon (HCL), Laboratoire Commun de Recherche Hospices Civils de Lyon – bioMérieux (Cancer Biomarkers Research Group), Hospices Civils de Lyon (HCL)-BIOMERIEUX, Hôpital Privé d'Antony, Centre Hospitalier de Béthune (CH Béthune), GHT de l'Artois, and COVADIS study group: Patrick Biston, Gwenhael Colin, Oriane de Maere, Nathan Ebstein, Stephan Ehrmann, Frederic Foret, Lionel Haentjens, Thibault Helbert, Jean-Baptiste Mesland, Celine Monard, Nicolas Mongardon, Gregoire Ottavy, Thomas Pasau, Gael Piton, Ester Ponzetto, Caroline Sejourne, Morgane Snacken, Xavier Souloy, Aude Sylvestre, Nicolas Tartrat, Cedric Vanbrussel
- Subjects
ARDS ,medicine.medical_specialty ,medicine.medical_treatment ,Remdesivir ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Lopinavir ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Intensive care ,Internal medicine ,medicine ,030212 general & internal medicine ,Renal replacement therapy ,Mechanical ventilation ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,Ritonavir ,business.industry ,Research ,Acute kidney injury ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,lcsh:RC86-88.9 ,medicine.disease ,Cohort ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,medicine.drug ,Hydroxychloroquine - Abstract
Background Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Methods Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was dichotomized into “patients still ventilated or dead at day 28” versus “patients weaned and alive at day 28”. Results We analyzed 415 patients (85 treated with standard of care (SOC), 57 with L/R, 220 with OHQ, and 53 others). The median number of d28-VFD was 0 (IQR 0–13) and differed between groups (P = 0.03), SOC patients having the highest d28-VFD. After adjustment for age, sex, Charlson Comorbidity Index, PaO2/FiO2 ratio and plateau pressure and accounting for center effect with a generalized linear mixed model, none of the antiviral strategies increased the chance of being alive and weaned from MV at day 28 compared to the SOC strategy (OR 0.48 CI95% (0.18–1.25); OR 0.96 (0.47–2.02) and OR 1.43 (0.53–4.04) for L/R, OHQ and other treatments, respectively). Acute kidney injury during ICU stay was frequent (55%); its incidence was higher in patients receiving lopinavir (66 vs 53%, P = 0.03). After adjustment for age, sex, BMI, chronic hypertension and chronic renal disease, the use of L/R was associated with an increased risk of renal replacement therapy (RRT). (OR 2.52 CI95% 1.16–5.59). Conclusion In this multicentre observational study of moderate-to-severe Covid-19 ARDS patients, we did not observe any benefit among patients treated with OHQ or L/R compared with SOC. The use of L/R treatment was associated with an increased need for RRT. Take home message Neither hydroxychloroquine nor lopinavir/ritonavir as COVID-19 antiviral treatment is associated with higher ventilator-free days at day 28 when compared with standard of care (no antiviral treatment) in ICU patients under invasive mechanical ventilation. Lopinavir/ritonavir is associated with an increased risk of renal replacement therapy requirement. Tweet COVID-19: Insights from ARDS cohort: no signal of efficacy of any antiviral drugs. Lopinavir/ritonavir may be associated with need for RRT
- Published
- 2020
16. Prevalence of Complete Airway Closure According to Body Mass Index in Acute Respiratory Distress Syndrome
- Author
-
Romy Younan, Remi Coudroy, Emmanuel Guerot, Jean Luc Diehl, Clotilde Bailleul, Amélie Couteau-Chardon, Aymeric Lancelot, Laurent Brochard, Nadia Aissaoui, Lu Chen, and Damien Vimpere
- Subjects
Adult ,Male ,medicine.medical_specialty ,ARDS ,Respiratory physiology ,Body Mass Index ,Cohort Studies ,Positive-Pressure Respiration ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Prevalence ,Humans ,Medicine ,Obesity ,Prospective Studies ,Respiratory system ,Aged ,Retrospective Studies ,Respiratory Distress Syndrome ,Lung ,Pulmonary gas pressures ,Respiratory distress ,business.industry ,030208 emergency & critical care medicine ,Middle Aged ,respiratory system ,medicine.disease ,Respiratory Function Tests ,Airway Obstruction ,Anesthesiology and Pain Medicine ,medicine.anatomical_structure ,030228 respiratory system ,Respiratory Mechanics ,Cardiology ,Female ,business ,Airway ,Body mass index - Abstract
Background Complete airway closure during expiration may underestimate alveolar pressure. It has been reported in cases of acute respiratory distress syndrome (ARDS), as well as in morbidly obese patients with healthy lungs. The authors hypothesized that complete airway closure was highly prevalent in obese ARDS and influenced the calculation of respiratory mechanics. Methods In a post hoc pooled analysis of two cohorts, ARDS patients were classified according to body mass index (BMI) terciles. Low-flow inflation pressure-volume curve and partitioned respiratory mechanics using esophageal manometry were recorded. The authors' primary aim was to compare the prevalence of complete airway closure according to BMI terciles. Secondary aims were to compare (1) respiratory system mechanics considering or not considering complete airway closure in their calculation, and (2) and partitioned respiratory mechanics according to BMI. Results Among the 51 patients analyzed, BMI was less than 30 kg/m in 18, from 30 to less than 40 in 16, and greater than or equal to 40 in 17. Prevalence of complete airway closure was 41% overall (95% CI, 28 to 55; 21 of 51 patients), and was lower in the lowest (22% [3 to 41]; 4 of 18 patients) than in the highest BMI tercile (65% [42 to 87]; 11 of 17 patients). Driving pressure and elastances of the respiratory system and of the lung were higher when complete airway closure was not taken into account in their calculation. End-expiratory esophageal pressure (ρ = 0.69 [95% CI, 0.48 to 0.82]; P Conclusions Prevalence of complete airway closure was high in ARDS and should be taken into account when calculating respiratory mechanics, especially in the most morbidly obese patients. : WHAT WE ALREADY KNOW ABOUT THIS TOPIC: Plateau and driving pressures have been shown to correlate with mortality in adult respiratory distress syndrome (ARDS). However, these static airway pressures may not always accurately reflect alveolar pressure.It has recently been recognized that in ARDS, airway closure may occur while some alveoli are still inflated. This may result in a biased estimate of mean alveolar pressure.Complete airway closure can only be measured by the inflection point on the initial portion of a low-flow inflation pressure-volume or pressure-time curve with the absence of cardiac oscillations and very low compliance, most likely in the terminal bronchioles.In 25 to 33% of patients with ARDS, airway opening pressure (the inflection point value) is greater than the total positive end-expiratory pressure measured by an end-expiratory maneuver. What this article tells us that is new In a post hoc analysis of two cohort studies of respiratory mechanics in ARDS, the authors compared the prevalence of complete airway closure stratified by body mass index and its effects on respiratory mechanics.Complete airway closure was present in 41% of patients, increasing with body mass index tercile (65% in the highest).Driving pressure and respiratory system elastances (lung, chest wall) were higher when complete airway closure was not adjusted for.
- Published
- 2020
17. Unusual internal injuries induced by fatal low-voltage electrocution: About two cases report
- Author
-
A. Aissaoui, S. Mannoubi, H. Limem, Ali Chadly, M.A. Mesrati, Y. Mahjoub, and Marwa Boussaid
- Subjects
medicine.medical_specialty ,business.industry ,030208 emergency & critical care medicine ,Autopsy ,Context (language use) ,medicine.disease ,people.cause_of_death ,Electrical Injuries ,Pathology and Forensic Medicine ,Surgery ,Electrical burn ,Electrocution ,03 medical and health sciences ,0302 clinical medicine ,Pneumothorax ,medicine.artery ,Pulmonary artery ,Medicine ,Thoracic aorta ,030216 legal & forensic medicine ,business ,people - Abstract
Summary Electrical injuries consist mainly in external burn marks. Internal injuries are rarely observed especially in low-voltage electrocution. In this context, we report two fatal cases due to electrocution by low voltage current (220 volts), with a special emphasis on pathological internal changes. Case no. 1 A 30-year-old male construction worker died after a low-voltage electrocution in the workplace. A medico-legal autopsy was required by judicial authorities. An external examination of the body showed marked facial cyanosis and electrical burn marks on the chest. The autopsy findings showed necrotic lesions of the heart, the thoracic aorta and pulmonary artery. The ischemic lesions were confirmed by histological tests. Case 2 A 20-year-old male was admitted to the Intensive Care Unit for pneumothorax after an accidental low-voltage electrocution. Despite cardiopulmonary reanimation, he died two hours later. An external examination of the corpse showed an electrical burn mark on the right hand. The autopsy findings revealed mainly a right pneumothorax as well as some necrotic lesions in the inferior lobe of the right lung and the anterior face of the liver, which were confirmed microscopically. Discussion-conclusion Death during electrocution by a low-voltage current is uncommon. Visceral necrosis is rarely described in this situation.
- Published
- 2020
18. Adult Still’s disease fatal evolution complicated with Macrophagic activation syndrome
- Author
-
A El Aissaoui, Salma Ksir, M.K. Moudden, Ali Zinebi, M El Aissate, S El Khader, and Noura Naji
- Subjects
Adult Still's disease ,business.industry ,Activation syndrome ,Immunology ,medicine ,General Medicine ,medicine.disease ,business - Published
- 2020
19. Rare association of aortoarteritis and pheochromocytoma: A case report
- Author
-
Brahim Housni, H. Latrech, H. Aissaoui, Mohammed Bouziane, Rachid Jabi, Nouha Elouafi, C. Toutai, Nabila Ismaili, and M. Berrajaa
- Subjects
endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Secondary hypertension ,Renal artery stenosis ,Pheochromocytoma ,03 medical and health sciences ,0302 clinical medicine ,Case report ,Occlusion ,medicine ,Right Renal Artery ,neoplasms ,business.industry ,medicine.disease ,Trunk ,Intermittent claudication ,Aortoarteritis ,Phyochromocytoma ,Stenosis ,nervous system ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Surgery ,Radiology ,medicine.symptom ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
Highlights • Pheochromocytoma is a great masquerador. • The coexistence of pheochromocytoma along with both aortoarteritis and renal artery stenosis is very rare. • Management of vascular abnormalities is based on the control of catecholamine release. • Pheochromocytoma should be included as differential diagnosis of aortoarteritis., Introduction Pheochromocytoma is an uncommon but treatable cause of secondary hypertension, it may present with a wide variety of manifestations. The coexistence of pheochromocytoma and vascular abnormalities is described but rarely reported entity. Presentation of case A 36-year-old man was admitted to our hospital for severe hypertension, examination revealed absent femoral pulses with notion of intermittent claudication. Abdominal computed tomography revealed the presence of a right adrenal pheochromocytoma. CT angiogram showed thickening of the thoracoabdominal aortic wall and the proximal portions of some of its branches with stenosis of more than 50% of the origin of the celiac trunk, bilateral occlusion of the external iliac arteries and trunk stenosis of the right renal artery. The Pheochromocytoma was surgically removed. Discussion Coexistence of pheyochromocytoma and vascular abnormalities especially renal artery stenosis and aortoarteritis seems to be an association rather than a coincidence. Conclusion To the best of our knowledge, the coexistence of pheochromocytoma along with both aortoarteritis and renal artery stenosis has not been reported thus far. The diagnosis, management and potential mechanisms underlying such an association will be discussed in this case.
- Published
- 2020
20. Clinical diagnosis, outcomes and treatment of thiamine deficiency in a tertiary hospital
- Author
-
François Mifsud, Nadia Aissaoui Balanant, Sébastien Czernichow, Claire Carette, Benoit Vedie, Léa Lucas-Martini, Tigran Poghosyan, Edouard Flamarion, Claire Rives-Lange, Diane Messager, Anne-Sophie Jannot, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Paris Cité - UFR Médecine Paris Centre [Santé] (UPC Médecine Paris Centre), Université Paris Cité (UPC), Health data- and model- driven Knowledge Acquisition (HeKA), Inria de Paris, Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)-Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPC)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPC), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Cognacq Jay, Université Paris Cité (UPCité), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), and Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138))
- Subjects
Neurological signs ,Male ,Pediatrics ,medicine.medical_specialty ,Parenteral Nutrition ,[SDV]Life Sciences [q-bio] ,Alcohol abuse ,Critical Care and Intensive Care Medicine ,Tertiary Care Centers ,chemistry.chemical_compound ,Risk Factors ,medicine ,Humans ,In patient ,Thiamine ,Medical prescription ,Thiamine deficiency ,Retrospective Studies ,Wernicke's encephalopathy ,Nutrition and Dietetics ,Alcohol-related disorders ,business.industry ,Malnutrition ,Brain ,food and beverages ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Alcoholism ,chemistry ,Clinical diagnosis ,Acute Disease ,Dietary Supplements ,Female ,business - Abstract
Summary Background Acute thiamine deficiency can occur in patients with or without history of alcohol abuse and can lead to life-threatening complications. Clinical diagnosis is challenging, often resulting in delayed recognition and treatment. Patients may present with heterogenous symptoms, more diverse than the historical neurological description. Cerebral MRI can contribute to the diagnosis in patients with neurological signs but it is not always feasible in emergency settings. Prompt parenteral supplementation is required to obtain the improvement of symptoms and avoid chronic complications. Aims To describe the clinical presentation of reported cases of thiamine deficiency, assess prescription and results of cerebral imaging, review treatments that had been prescribed in accordance or not with available guidelines, and study the short-term outcome of these patients. Methods This is a monocentric retrospective analysis of all reported cases of thiamine deficiency in a French tertiary hospital between January 1st 2008 and December 31st 2018. Results Fifty-six cases were identified during the study period. Forty-five (80%) patients had a history of alcohol abuse. Most patients were diagnosed based on neurological symptoms but non-specific and digestive symptoms were frequent. Thirty-four percent of patients fulfilled clinical criteria for malnutrition. A brain MRI was performed in 54% of patients and was abnormal in 63% of these cases. Eighty-five percent of patients were treated by parenteral thiamine administration and the supplementation was continued orally in 55% of them. The majority of patients initially received 1000 mg daily of IV thiamine but the dose and duration of thiamine supplementation were variable. At the time of discharge, partial or complete improvement of symptoms was noted in 59% of patients. Conclusion This study highlights the clinical and radiological heterogeneity of thiamine deficiency. These observations should encourage starting thiamine supplementation early in patients with risk factors or suggestive symptoms even in non-alcoholic patients, and underline the importance of early nutritional support.
- Published
- 2022
21. Emergency stay triggered Tako-Tsubo syndrome: A case report and review of the literature
- Author
-
N Ismaili, N Elouafi, R Bougrine, H. Aissaoui, and Y Hdidou
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Cardiomyopathy ,Cardiology ,Medicine ,Tako tsubo ,business ,medicine.disease ,Clinical syndrome - Abstract
Tako-Tsubo cardiomyopathy is an increasingly recognized as clinical syndrome characterized by transient apical left ventricular dysfunction.
- Published
- 2019
22. Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study
- Author
-
Vandenbunder, Benoit, Ehrmann, Stephan, Piagnerelli, Michael, Sauneuf, Bertrand, Serck, Nicolas, Soumagne, Thibaud, Textoris, Julien, Vinsonneau, Christophe, Aissaoui, Nadia, Blonz, Gauthier, Carbutti, Giuseppe, Courcelle, Romain, D'hondt, Alain, Gaudry, Stephane, Higny, Julien, Horlait, Geoffrey, Hraiech, Sami, Lefebvre, Laurent, Lejeune, Francois, Ly, Andre, Lascarrou, Jean-Baptiste, Grimaldi, David, COVADIS study group, Mesland, Jean-Baptiste, Service de Médecine Intensive Réanimation [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 (CEPR), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/DDUV - Institut de Duve, UCL - SSS/DDUV/GECE - Génétique cellulaire, UCL - (SLuc) Service de soins intensifs, and UCL - (MGD) Services des soins intensifs
- Subjects
Male ,ARDS ,medicine.medical_specialty ,animal structures ,medicine.medical_treatment ,Respiratory mechanics ,Respiratory physiology ,SARS-COV-2 ,Pulmonary compliance ,Critical Care and Intensive Care Medicine ,Logistic regression ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Mechanical ventilation ,Internal medicine ,medicine ,otorhinolaryngologic diseases ,Humans ,Mortality ,PEEP ,Aged ,Respiratory Distress Syndrome ,business.industry ,Research ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,COVID-19 ,030208 emergency & critical care medicine ,lcsh:RC86-88.9 ,Middle Aged ,Plateau pressure ,respiratory system ,medicine.disease ,030228 respiratory system ,Cohort ,ICU ,Breathing ,Female ,business ,Cohort study - Abstract
BackgroundControversies exist on the nature of COVID-19 related acute respiratory distress syndrome (ARDS) in particular on the static compliance of the respiratory system (Crs). We aimed to analyze the association of Crs with outcome in COVID-19-associated ARDS, to ascertain its determinants and to describe its evolution at day-14.MethodsIn this observational multicenter cohort of patients with moderate to severe Covid-19 ARDS, Crs was measured at day-1 and day-14. Association between Crs or Crs/ideal body weight (IBW) and breathing without assistance at day-28 was analyzed with multivariable logistic regression. Determinants were ascertained by multivariable linear regression. Day-14 Crs was compared to day-1 Crs with paired t-test in patients still under controlled mechanical ventilation.ResultsThe mean Crs in 372 patients was 37.6 ± 13 mL/cmH2O, similar to as in ARDS of other causes. Multivariate linear regression identified chronic hypertension, low PaO2/FiO2ratio, low PEEP, and low tidal volume as associated with lower Crs/IBW. After adjustment on confounders, nor Crs [OR 1.0 (CI 95% 0.98–1.02)] neither Crs/IBW [OR 0.63 (CI 95% 0.13–3.1)] were associated with the chance of breathing without assistance at day-28 whereas plateau pressure was [OR 0.93 (CI 95% 0.88–0.99)]. In a subset of 108 patients, day-14 Crs decreased compared to day-1 Crs (31.2 ± 14.4 mL/cmH2O vs 37.8 ± 11.4 mL/cmH2O,p ConclusionIn a large multicenter cohort of moderate to severe COVID-19 ARDS, mean Crs was decreased below 40 mL/cmH2O and was not associated with day-28 outcome. Crs decreased between day-1 and day-14 but the decrease was not associated with day-28 outcome.
- Published
- 2021
23. Leser-Trelat sign preceding male breast cancer
- Author
-
Nada Zizi, Siham Dikhaye, Hasnae Saddouk, Asmae Aissaoui, Amal Bennani, Soraya Aouali, and Sara Bensalem
- Subjects
medicine.medical_specialty ,Seborrheic keratoses ,business.industry ,Leser-Trélat sign ,Case Report ,Paraneoplastic dermatoses ,General Medicine ,medicine.disease ,Dermatology ,Male breast cancer ,medicine ,Surgery ,medicine.symptom ,business ,Leser–Trélat sign ,Sign (mathematics) - Abstract
Introduction Leser-Trelat sign is a paraneoplastic marker characerized by the abrupt appearance of seborrheic keratoses. It is described in association with many underlying malignant diseases. Case report We report a case of coexistence of two rare entities, represented by the Leser-Trelat sign occurring with male breast cancer. Discussion The asscociation of male breast cancer and LT sign is decidedly unusual. To our knowledge, our case report is the second to describe the association of these two rare entities. Conclusion A proper dermatological examination and a good knowledge of cutaneous paraneoplastic syndromes can be of great help in screening for multiple skin cancers., Highlights • Leser-Trelat sign is a paraneoplastic marker characerized by the abrupt appearance of seborrheic keratoses. • We report the case of a male with a breast cancer preceeded by a Leser-Trélat sign. • Our case report highlights the importance of a good knowledge of paraneoplastic dermatoses that can be alarming signs to serious underlying malgnancies.
- Published
- 2021
24. Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study
- Author
-
Labbé, Vincent, Ederhy, Stephane, Lapidus, Nathanael, Joffre, Jérémie, Razazi, Keyvan, Laine, Laurent, Sy, Oumar, Voicu, Sebastian, Chemouni, Frank, Aissaoui, Nadia, Smonig, Roland, Doyen, Denis, Carrat, Fabrice, Voiriot, Guillaume, Mekontso-Dessap, Armand, Cohen, Ariel, Fartoukh, Muriel, Guidet, Bertrand, Ait-Oufella, Hafid, Bourcier, Simon, da Silva, Daniel, Jochmans, Sebastien, Dellamonica, Jean, Timsit, Jean-François, Megarbane, Bruno, Diehl, Jean-Luc, Rushton-Smith, Sophie, Service de Réanimation et USC Médico-Chirurgicale = Médecine intensive réanimation [CHU Tenon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Groupe de recherche clinique CARMAS (Cardiovascular and Respiratory Manifestations of Acute lung injury and Sepsis) (CARMAS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Henri Mondor, Département Médico-Universitaire APPROCHES, Service de Cardiologie [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Thrombose, atherothrombose et pharmacologie appliquée, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service de santé publique [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Service de Réanimation Médicale [CHU Saint-Antoine], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre Hospitalier de Saint-Denis [Ile-de-France], Centre Hospitalier de Melun (CHM), Service de Réanimation Médicale et Toxicologique [Hôpital Lariboisière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Gustave Roussy (IGR), Département d'anesthésie, réanimation et pathologie infectieuse (DARPI), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier Universitaire de Nice (CHU Nice), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases [IHU ICAN], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), HAL-SU, Gestionnaire, Service de Réanimation et USC Médico-Chirurgicale [CHU Tenon], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor, Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier de Melun, Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Groupe Henri Mondor-Albert Chenevier, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Hôpital Albert Chenevier, Université Paris Descartes - Paris 5 (UPD5), Unité de Recherche Clinique de la Côte d’Azur [Nice] (URRIS UR2CA), Université Côte d'Azur (UCA), Sorbonne Université - Faculté de Médecine (SU FM), FAST Study Group: Bertrand Guidet, Hafid Ait-Oufella, Simon Bourcier, Daniel Da Silva, Sebastien Jochmans, Jean Dellamonica, Jean-François Timsit, Bruno Megarbane, Jean-Luc Diehl, Sophie Rushton-Smith, and WEISS, Nicolas
- Subjects
medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,Atrial fibrillation Transesophageal echocardiography Stroke Bleeding Sepsis ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Anesthesiology ,medicine ,030212 general & internal medicine ,cardiovascular diseases ,Thrombus ,Transesophageal echocardiography ,Stroke ,RC86-88.9 ,business.industry ,Septic shock ,Research ,Incidence (epidemiology) ,Hazard ratio ,Bleeding ,Medical emergencies. Critical care. Intensive care. First aid ,Atrial fibrillation ,medicine.disease ,3. Good health ,[SDV] Life Sciences [q-bio] ,Cardiology ,cardiovascular system ,business - Abstract
Background Echocardiographic parameters have been poorly investigated for estimating cardiovascular risk in patients with sepsis and new-onset atrial fibrillation. We aim to assess the prevalence of transesophageal echocardiographic abnormalities and their relationship with cardiovascular events in mechanically ventilated patients with sepsis and new-onset atrial fibrillation. Methods In this prospective multicenter pilot study, left atrial/left atrial appendage (LA/LAA) dysfunction, severe aortic atheroma, and left ventricular systolic dysfunction were assessed using an initial transesophageal echocardiographic study, which was repeated after 48–72 h to detect LA/LAA thrombus formation. The study outcome was a composite of cardiovascular events at day 28, including arterial thromboembolic events (ischemic stroke, non-cerebrovascular arterial thromboembolism, LA/LAA thrombus), major bleeding, and all-cause death. Results The study population comprised 94 patients (septic shock 63%; 35% women; median age 69 years). LA/LAA dysfunction, severe aortic atheroma, and left ventricular systolic dysfunction were detected in 17 (19%), 22 (24%), and 27 (29%) patients, respectively. At day 28, the incidence of cardiovascular events was 46% (95% confidence interval [CI]: 35 to 56). Arterial thromboembolic events and major bleeding occurred in 7 (7%) patients (5 ischemic strokes, 1 non-cerebrovascular arterial thromboembolism, 2 left atrial appendage thrombi) and 18 (19%) patients, respectively. At day 28, 27 patients (29%) died. Septic shock (hazard ratio [HR]: 2.36; 95% CI 1.06 to 5.29) and left ventricular systolic dysfunction (HR: 2.06; 95% CI 1.05 to 4.05) were independently associated with cardiovascular events. Conclusions Transesophageal echocardiographic abnormalities are common in mechanically ventilated patients with sepsis and new-onset atrial fibrillation, but only left ventricular systolic dysfunction was associated with cardiovascular events at day 28.
- Published
- 2021
25. Acute Severe Asthma: Changes in Patient Characteristics, Management, and Outcomes over a Period of 20 Years (1997 to 2017), Insights from Cub-Réa Network
- Author
-
Francesca Santi, Romy Younan, Ana Novara, Amer Hamdan, Jean Loup Augy, JL Diehl, Caroline Hauw-Berlemont, Clotilde Bailleul, Bertrand Guidet, Nicolas Peron, Bertrand Hermann, Nadia Aissaoui, Philippe Aegerter, and Emmanuel Guerot
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Acute severe asthma ,Period (gene) ,medicine ,In patient ,business ,medicine.disease - Abstract
Background: While acute severe asthma (ASA) is the leading cause of emergency department visits and the third cause of hospitalization in children younger than 18 years old, there is a lack of data regarding adult patients admitted in intensive care units (ICU) for ASA. We aimed to describe the evolutions in epidemiology, management, and outcomes of ASA in adult patients, over a period of twenty years in the Greater Paris area ICUs (CUB-Réa Database). Methods: Demographics, severity and supportive treatments were collected from the CUB-Réa Database. The primary endpoint was the prevalence of ASA by periods of 5 years. The secondary endpoints were in-ICU survival, in-hospital survival, use of mechanical ventilation including non-invasive and invasive and catecholamine. Multivariate analysis was performed to assess correlating factors of ICU Mortality. Results: Of the 475 357 ICU admissions from January 1997 to January 2016, 7049 were admitted for ASA with a decreasing prevalence over time, respectively 2.8%, 1.7%, 1.1%, and 1.1% of total ICU admissions (p Conclusion: ICU admission for ASA remains uncommon and decreases over time. Despite an increasing severity of patients and the use of mechanical ventilation, the use of catecholamine decreases with high in-ICU survival rate which could be related to a better management of mechanical ventilation.
- Published
- 2021
26. Case Report: Potential Role of Corticosteroids in the Management of Post-COVID-19 Pneumonia
- Author
-
Houari Aissaoui, Anaïs Eskenazi, Valentin Suteau, Antoine Adenis, and Kinan Drak Alsibai
- Subjects
ARDS ,Medicine (General) ,corticosteroid ,organizing pneumonia ,medicine.medical_treatment ,severe COVID-19 pneumonia ,Case Report ,medicine.disease_cause ,law.invention ,R5-920 ,law ,Oxygen therapy ,medicine ,interstitial lung diseases ,Respiratory system ,post-COVID-19 infection ,Lung ,business.industry ,General Medicine ,medicine.disease ,Intensive care unit ,Pulmonary embolism ,Pneumonia ,medicine.anatomical_structure ,Superinfection ,Anesthesia ,Medicine ,business - Abstract
Certain patients who recover from severe pneumonia due to coronavirus disease 2019 (COVID-19) remain symptomatic in the post-infectious period, either clinically, radiologically, or respiratory. The post-COVID-19 period is characterized by clinical symptoms of varying duration from one subject to another and does not seem to depend on the severity of initial pneumonia. The persisting inflammatory and/or immune reactions in the post-COVID-19 period may play a role in the development of pulmonary lesions. Here, we report the case of a 61-year-old man with severe COVID-19 pneumonia, complicated by acute respiratory distress syndrome and pulmonary embolism, which required the patient's admission to the intensive care unit and high-flow oxygen therapy. The patient was hospitalized for 23 days for the management of his severe COVID-19 pneumonia. Afterwards, he was discharged home following a negative SARS-CoV-2 PCR test. The post-COVID-19 period was characterized by a complex respiratory symptomatology associating cough, resting dyspnea, and exertional dyspnea requiring oxygen therapy for several weeks. Surprisingly, the follow-up chest CT scan performed 4 weeks after discharge revealed bilateral interstitial lung lesions. After ruling out pulmonary superinfection, the patient was treated with oral corticosteroid for 3 months at a digressive dose. In our case, the use of corticosteroid therapy in the post-COVID19 phase had improved the outcome of the lung disease. These benefits are characterized by a rapid symptomatic improvement, accelerated repair of pulmonary images, rapid oxygen withdrawal, and rapid return to daily activities.
- Published
- 2021
- Full Text
- View/download PDF
27. Sudden death and hydatid cyst: A medicolegal study
- Author
-
Said Saadi, Abir Aissaoui, M. Belhadj, Ali Chadly, Imen Hmila, Sami Ben Jomaa, and Nidhal Haj Salem
- Subjects
Adult ,Male ,medicine.medical_specialty ,Tunisia ,Autopsy ,Disease ,01 natural sciences ,Sudden death ,Pathology and Forensic Medicine ,Death, Sudden ,03 medical and health sciences ,0302 clinical medicine ,Echinococcosis ,Cause of Death ,parasitic diseases ,Epidemiology ,medicine ,Humans ,Cyst ,030216 legal & forensic medicine ,Anaphylaxis ,Retrospective Studies ,business.industry ,General surgery ,010401 analytical chemistry ,medicine.disease ,Hemothorax ,0104 chemical sciences ,Pulmonary embolism ,Issues, ethics and legal aspects ,Female ,Complication ,business - Abstract
The discovery of a hydatid cyst at autopsy poses the problem of its involvement in the mechanism of death. The aim of this study is to analyse the epidemiological and etiopathogenic characteristics of death attributed to hydatid disease, to discuss the mechanism of death and to propose preventive measures. This is a retrospective descriptive study of 26 cases of death with hydatid cyst autopsic discovered, collected at the forensic department of Fattouma Bourguiba University Hospital of Monastir (Tunisia) over a period of 27 years (from 1990 until 2017). In 26 cases, hydatid cyst was observed during autopsy of sudden death cases, which corresponds to 0.33% of the total of autopsies in this period. Of the 26 victims, 13 (50%) were men; the mean age was 43 years. Most victims were from rural zones (18 cases). In 20 cases, the complicated cyst was hepatic. It was cardiac in two cases. Of all cases, three cysts were cracked, and nine were broken. Of the 26 cases, only 15 were implicated in the death mechanism. Death was attributed to anaphylaxis in 12 cases, hydatid pulmonary embolism in 1 case, cardiac arythmia in one case and hemothorax in one case. Sudden death is the most dangerous complication of the hydatid cyst which can be discovered at autopsy. Several causes may explain its occurrence, the most common of which is anaphylactic shock.
- Published
- 2019
28. Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries
- Author
-
Debiec, Hanna, Dossier, Claire, Letouzé, Eric, Gillies, Christopher, Vivarelli, Marina, Putler, Rosemary, Ars, Elisabet, Jacqz-Aigrain, Evelyne, Elie, Valery, Colucci, Manuela, Debette, Stéphanie, Amouyel, Philippe, Elalaoui, Siham, Sefiani, Abdelaziz, Dubois, Valérie, Kretzler, Matthias, Ballarin, Jose, Emma, Francesco, Sampson, Matthew, Deschênes, Georges, Ronco, Pierre, Ederhy, Stephane, Cohen, Ariel, Boccara, Franck, Aissaoui, Nadia, Elbaz, Meyer, Bonnefoy-Cudraz, Eric, Druelles, Philipe, Andrieu, Stéphane, Angoulvant, Denis, Furber, Alain, Cottin, Yves, Puymirat, Etienne, Bonaca, Marc, Iliou, Marie-Christine, Tea, Victoria, Ducrocq, Grégory, Douard, Hervé, Labrunee, Marc, Plastaras, Philoktimon, Chevallereau, Pierre, Taldir, Guillaume, Bataille, Vincent, Ferrières, Jean, Schiele, François, Simon, Tabassome, Danchin, Nicolas, Centre de Ressources Biologiques APHP-SU (PASS-CRB-APHP-SU), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), and Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,Time Factors ,MESH: Registries ,health care facilities, manpower, and services ,[SDV]Life Sciences [q-bio] ,medicine.medical_treatment ,Cardiac rehabilitation ,030204 cardiovascular system & hematology ,MESH: Risk Assessment ,MESH: Aged, 80 and over ,0302 clinical medicine ,Risk Factors ,MESH: Risk Factors ,Medicine ,Registries ,MESH: Cardiac Rehabilitation ,030212 general & internal medicine ,Myocardial infarction ,Atherothrombotic risk stratification ,Non-ST Elevated Myocardial Infarction ,health care economics and organizations ,Cancer ,MESH: Treatment Outcome ,Aged, 80 and over ,MESH: Aged ,education.field_of_study ,MESH: Middle Aged ,Framingham Risk Score ,Rehabilitation ,nephrotic syndrome ,MESH: Polymorphism, Single Nucleotide ,Hazard ratio ,Score ,genetic renal disease ,General Medicine ,Middle Aged ,MESH: Recovery of Function ,3. Good health ,In-hospital mortality ,Treatment Outcome ,Stratification risque athérothrombotique ,cardiovascular system ,Female ,France ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,pediatrics ,education ,Population ,Infarctus du myocarde ,Acute myocardial infarction ,Mortalité ,MESH: Phenotype ,Risk Assessment ,03 medical and health sciences ,Intensive care ,Internal medicine ,MESH: Spain ,Humans ,cardiovascular diseases ,Mortality ,Réadaptation cardiaque ,MESH: ST Elevation Myocardial Infarction ,Medical prescription ,Aged ,focal segmental glomerulosclerosis ,genome-wide association study ,MESH: Humans ,business.industry ,MESH: Time Factors ,MESH: Italy ,Recovery of Function ,medicine.disease ,MESH: Male ,MESH: Quantitative Trait Loci ,MESH: Steroids ,Confidence interval ,MESH: France ,MESH: Non-ST Elevated Myocardial Infarction ,gene expression ,Mortalité hospitalière ,ST Elevation Myocardial Infarction ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Nephrotic Syndrome ,business ,MESH: Female - Abstract
Cardiac rehabilitation is strongly recommended in patients after acute myocardial infarction.To assess cardiac rehabilitation prescription after acute myocardial infarction according to predicted risk, and its association with 1-year mortality, using the FAST-MI registries.We used data from three 1-month French nationwide registries, conducted 5 years apart from 2005 to 2015, including 13130 patients with acute myocardial infarction admitted to coronary or intensive care units. Atherothrombotic risk stratification was performed using the Thrombolysis In Myocardial Infarction Risk Score for Secondary Prevention (TRS-2P). Patients were classified into three categories: Group 1 (low risk; no or one risk indicator; score of 0 or 1); Group 2 (intermediate risk; two risk indicators; score of 2); and Group 3 (high risk; at least three risk indicators; score of≥3).Among the 12291 patients, cardiac rehabilitation prescription was 43.6% (49.9% in Group 1; 43.0% in Group 2; 35.2% in Group 3). Using Cox multivariable analysis, cardiac rehabilitation prescription was associated with lower mortality at 1 year in the overall population (3.8% vs. 8.2%; hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.61-0.85; P0.001). Cardiac rehabilitation was associated with improved 1-year mortality, with homogeneous relative risk reductions in low- and intermediate-risk categories (HR 0.70, 95% CI 0.51-0.94) compared with high-risk patients (HR 0.72, 95% CI 0.59-0.88). In absolute terms, however, mortality decrease associated with cardiac rehabilitation was positively correlated with risk level (Group 1, 0.9% vs. 2.4%; Group 2, 3.0% vs. 4.2%; Group 3, 10.5% vs. 17.3%).Cardiac rehabilitation prescription was inversely correlated with patient risk. A positive association between cardiac rehabilitation and 1-year survival after acute myocardial infarction was present whatever the risk level, but the greatest mortality reduction was observed in high-risk patients.
- Published
- 2019
29. Acute aortic dissection mimicking a gastric ulcer: Medico‐legal implications
- Author
-
A. Zakhama, Abir Aissaoui, Marwa Boussaid, Nouha Ben Abdejlil, and Med Amin Mesrati
- Subjects
Medico legal ,medicine.medical_specialty ,lcsh:Medicine ,sudden death ,Autopsy ,Case Report ,Case Reports ,030204 cardiovascular system & hematology ,Retrosternal pain ,Sudden death ,03 medical and health sciences ,Aortic aneurysm ,0302 clinical medicine ,autopsy ,medicine ,legal ,Aortic dissection ,lcsh:R5-920 ,business.industry ,General surgery ,lcsh:R ,Medical practice ,General Medicine ,medicine.disease ,030220 oncology & carcinogenesis ,Differential diagnosis ,liability ,business ,lcsh:Medicine (General) ,aortic aneurysm - Abstract
The diagnosis of aortic dissection is often difficult because the symptoms are usually non‐specific. AD should be considered in the differential diagnosis of all cases of idiopathic retrosternal pain. Misdiagnosis of AD is a common cause of legal suits in medical practice. Prevention requires a complete and thorough evaluation.
- Published
- 2019
30. Cultivar dependent impact of soil amendment with water retaining polymer on olive (Olea europaea L.) under two water regimes
- Author
-
Tommaso del Giudice, Olfa Dabbaghi, Feten Aissaoui, Hechmi Chehab, Naouraz M’barki, Beligh Mechri, and Dalenda Boujnah
- Subjects
biology ,Chemistry ,0208 environmental biotechnology ,Amendment ,Soil Science ,Greenhouse ,04 agricultural and veterinary sciences ,02 engineering and technology ,biology.organism_classification ,medicine.disease ,Photosynthesis ,020801 environmental engineering ,Horticulture ,Olea ,040103 agronomy & agriculture ,medicine ,0401 agriculture, forestry, and fisheries ,Cultivar ,Dehydration ,Agronomy and Crop Science ,Water content ,Chlorophyll fluorescence ,Earth-Surface Processes ,Water Science and Technology - Abstract
Hydrogels have a large interest for commercial application in agriculture. Our experiment was performed under greenhouse conditions, to examine the effect of the hydrogel “stockosorb-660” (TS) compared with non treated plants (TC). As compared to TC treatment, the hydrogel treatment increased clearly the growth responses, photosynthetic pigments, the dry weights and the relative water content of olive plantlets mainly in chemlali cv and under drought stress. Under drought stress, the chlorophyll fluorescence measurements were about 0.53 and 0.36 for chemlali and chetoui cultivars, respectively using TS treatment. In the same treatment, as compared to control plantlets, total phenols decreased damages under drought stress and were about 53.94 mg g−1 GAE and 57.37 mg g−1 GAE for chemlali and chetoui cultivars, respectively. Our results confirm also that “stockosorb” hydrogel is a cultivar dependent and seems to be probably suitable for agricultural use because of its capacity to avoid dehydration damages of young olive plants.
- Published
- 2019
31. Cytological Spectrum of Pulmonary Histoplasmosis Diagnosed by Bronchoalveolar Lavage: 12 Years of Experience in French Guiana
- Author
-
Denis Blanchet, Houari Aissaoui, Morgane Bourne-Watrin, Félix Djossou, Pierre Couppié, Loïc Epelboin, Antoine Adenis, Magalie Demar, Kinan Drak Alsibai, and Mathieu Nacher
- Subjects
0301 basic medicine ,Microbiology (medical) ,Pulmonary histoplasmosis ,Pathology ,medicine.medical_specialty ,QH301-705.5 ,030231 tropical medicine ,Patient characteristics ,Plant Science ,Histoplasma capsulatum ,Histoplasmosis ,Article ,Lymphocytic Infiltrate ,03 medical and health sciences ,0302 clinical medicine ,cytopathology ,Cytology ,medicine ,histoplasma capsulatum ,bronchoalveolar lavage ,clustering pattern ,Biology (General) ,Ecology, Evolution, Behavior and Systematics ,medicine.diagnostic_test ,biology ,business.industry ,histoplasmosis ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,Bronchoalveolar lavage ,Cytopathology ,business - Abstract
Disseminated histoplasmosis is a major cause of mortality in HIV-infected patients. Rapid and efficient diagnosis of Histoplasma capsulatum is crucial. Cytopathology is available in most hospitals and represents a rapid diagnostic alternative. In this study, we reviewed 12 years of experience to describe the cytology of histoplasmosis diagnosed by bronchoalveolar lavage (BAL) in relation to patient characteristics. BAL-diagnosed pulmonary histoplasmosis concerned 17 patients (14 HIV+). BAL cellularity ranged from 76,000 to 125,000 cells/mL in HIV patients, and 117,000 to 160,000 cells/mL in non-HIV patients. Macrophages predominated in all HIV patients (from 60% to 88%), lymphocytic infiltrates ranged from 5% to 15%, and neutrophils were very heterogeneous (from 2% to 32%). The number of H. capsulatum at hot spots seemed greater in HIV-infected than in immunocompetent patients (9 to 375 vs. 4 to 10) and were inversely proportional to the CD4 counts. Yeasts were both intracellular and extracellular in 85.7% of the HIV patients. This is the most comprehensive series detailing the cytological aspects of BAL in the diagnosis of H. capsulatum, focusing on the number of yeasts and their clustering pattern. The cytological examination of the Gomori-Grocott-stained BAL allows a reliable diagnosis of histoplasmosis.
- Published
- 2021
32. Increased sensitivity of a new commercial reverse transcriptase-quantitative PCR for the detection of Pneumocystis jirovecii in respiratory specimens
- Author
-
Alexandre Alanio, Maud Gits-Muselli, Stéphane Bretagne, Samia Hamane, Nesrine Aissaoui, Sarah Dellière, Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris] (IP), Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], and Institut Pasteur [Paris]
- Subjects
Adult ,Male ,diagnosis ,Respiratory System ,Opportunistic Infections ,Pneumocystis pneumonia ,Pneumocystis carinii ,Real-Time Polymerase Chain Reaction ,[SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics, Phylogenetics and taxonomy ,Sensitivity and Specificity ,law.invention ,Extractor ,03 medical and health sciences ,law ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,medicine ,Pneumocystis jirovecii ,Humans ,Respiratory system ,Polymerase chain reaction ,[SDV.MP.MYC]Life Sciences [q-bio]/Microbiology and Parasitology/Mycology ,030304 developmental biology ,Aged ,0303 health sciences ,biology ,030306 microbiology ,business.industry ,Reverse Transcriptase Polymerase Chain Reaction ,Pneumonia, Pneumocystis ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Virology ,Reverse transcriptase ,3. Good health ,mitochondria ,Pneumonia ,real time PCR ,Infectious Diseases ,Real-time polymerase chain reaction ,Female ,business - Abstract
Optimal sensitivity to detect low Pneumocystis loads is of importance to take individual and collective measures to avoid evolution towards Pneumocystis pneumonia and outbreaks in immunocompromised patients. This study compares two qPCR procedures, a new automated RTqPCR using the GeneLEAD VIII extractor/thermocycler (GLVIII; ∼2.2 h workflow) and a previously validated in-house qPCR assays (IH; ∼5 h workflow) both targeting mtSSU and mtLSU for detecting P. jirovecii in 213 respiratory samples. GLVIII was found to be more sensitive than IH, detecting eight more specimens. Bland-Altman analysis between the two procedures showed a Cq bias of 1.17 ± 0.07 in favor of GLVIII. Lay Summary The fungus Pneumocystis needs to be detected early in respiratory samples to prevent pneumonia in immunocompromised hosts. We evaluated a new commercial RTqPCR on 213 respiratory samples to detect Pneumocystis and found it more sensitive and faster than our routine sensitive in-house qPCR assay.
- Published
- 2021
33. Melanotransferrin is efficiently sorted on the surface of exosomes secreted by melanoma cells
- Author
-
Gaëtan Bellot, Nesrine Aissaoui, Laurent Henry, Marie Morille, Michel Vidal, Anne Bonhoure, Pierre-Emmanuel Stoebner, Dynamique des interactions membranaires normales et pathologiques (DIMNP), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université Montpellier 1 (UM1), Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut Charles Gerhardt Montpellier - Institut de Chimie Moléculaire et des Matériaux de Montpellier (ICGM ICMMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut de Chimie du CNRS (INC), Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Biochimie Structurale [Montpellier] (CBS), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Centre National de la Recherche Scientifique (CNRS)
- Subjects
Cancer Research ,Skin Neoplasms ,Dermatology ,Exosomes ,Mice ,Melanoma Biomarker ,medicine ,Animals ,Humans ,[CHIM]Chemical Sciences ,Melanoma ,neoplasms ,ComputingMilieux_MISCELLANEOUS ,Membrane Glycoproteins ,CD63 ,biology ,Chemistry ,medicine.disease ,Microvesicles ,3. Good health ,Oncology ,Cutaneous melanoma ,Cancer cell ,biology.protein ,Cancer research ,Melanotransferrin ,Antibody - Abstract
Cutaneous melanoma is the most lethal type of skin cancer. Early detection is crucial to improve the outcome of melanoma patients. The identification of noninvasive prognostic biomarkers for the follow-up of melanoma patients is still in demand for clinical use. We show here that exosomal melanotransferrin fulfills the biomarker characteristics required to meet this demand. Melanotransferrin is typically overexpressed in melanoma cells compared to other cell types - including cancer cells - and is efficiently sorted and secreted with nanovesicles, or so-called exosomes, due to its membrane-anchoring by a glycosylphosphatidylinositol. Melanotransferrin is exposed on the surface of exosomes and is accessible for antibody recognition. An ELISA was set up to quantify melanotransferrin after immobilization of nanovesicles through the exosomal constituent tetraspanins CD63. Melanotransferrin was detected using a low number of exosomes purified from melanoma cell line cultures, and melanotransferrin detection was abolished by phosphatidylinositol-specific phospholipase C treatment. This exosomal melanotransferrin ELISA was able to discriminate an equal number of assayed exosomes purified from two different melanoma cell lines (A-375 vs. SK-MEL-28). Moreover, plasma samples from patients with melanoma and noncancer disease were assayed using this ELISA and elevated levels of exosomal melanotransferrin were seen in the plasma of patients with melanoma. We propose that exosomal melanotransferrin should be assessed as a potential melanoma biomarker.
- Published
- 2021
34. Incidental Asymptomatic Giant Hydatid Cyst of the Interventricular Septum Bulging Into the Right Ventricle
- Author
-
Nabila Ismaili, Ramia Bougrine, Hanane Aissaoui, and Noha Elouafi
- Subjects
medicine.medical_specialty ,Cardiology ,Infectious Disease ,Hydatid cyst ,Computed tomography ,030204 cardiovascular system & hematology ,Asymptomatic ,echinococcus granulosus ,03 medical and health sciences ,0302 clinical medicine ,parasitic diseases ,medicine ,asymptomatic ,Interventricular septum ,Echinococcus granulosus ,hydatid cyst ,biology ,medicine.diagnostic_test ,business.industry ,General Engineering ,biology.organism_classification ,medicine.disease ,ventricular septum ,medicine.anatomical_structure ,Ventricle ,cardiovascular system ,Acute pancreatitis ,Radiology ,Cystic mass ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Hydatid disease is caused by the larvae of Echinococcus granulosus. Domestic animals like cats and dogs are the primary carriers of echinococcal organisms. This parasitosis is still endemic in some particular regions of the world. The cardiac hydatid cyst is an exceptional infection. We report a case of an asymptomatic giant cardiac hydatid cyst in the interventricular septum (IVS) protruding in the right ventricular diagnosed incidentally by scan tomography during acute pancreatitis emergency. Transthoracic echocardiography revealed a cystic mass in the IVS bulging into the right ventricle. The diagnosis was confirmed by a cardiac CT scan.
- Published
- 2021
35. IMPELLA® or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
- Author
-
André Vincentelli, Gilles Lemesle, Guillaume Schurtz, Emmanuel Robin, Cedric Delhaye, Nicolas Lamblin, Eric Van Belle, Ouriel Saura, Clément Delmas, Sina Porouchani, Francis Juthier, Flavien Vincent, Etienne Puymirat, Laurent Bonello, M Moussa, N Rousse, Alessandro Cosenza, Vincent Balmette, Nadia Aissaoui, Basile Verdier, Institut Coeur Poumon [CHU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires (RNMCD - U1011), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Alliance française pour les essais cliniques cardio-vasculaires - French Alliance for Cardiovascular Trials (FACT), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Paris Descartes - Paris 5 (UPD5), Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Mediterranean Association for Research and Studies in Cardiology (MARS cardio), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 (RNMCD), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Lucas, Nelly
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,lcsh:Medicine ,030204 cardiovascular system & hematology ,Article ,IMPELLA(®) ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,Internal medicine ,IMPELLA® ,medicine ,Extracorporeal membrane oxygenation ,Clinical endpoint ,030212 general & internal medicine ,Impella ,mechanical circulatory support ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,business.industry ,Cardiogenic shock ,Significant difference ,lcsh:R ,cardiogenic shock ,General Medicine ,extracorporeal membrane oxygenation ,medicine.disease ,medicine.anatomical_structure ,surgical procedures, operative ,Ventricle ,Circulatory system ,Cardiology ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Mechanical circulatory support (MCS) devices are effective tools in managing refractory cardiogenic shock (CS). Data comparing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and IMPELLA® are however scarce. We aimed to assess outcomes of patients implanted with these two devices and eligible to both systems. From 2004 to 2020, we retrospectively analyzed 128 patients who underwent VA-ECMO or IMPELLA® in our institution for refractory left ventricle (LV) dominant CS. All patients were eligible to both systems: 97 patients were first implanted with VA-ECMO and 31 with IMPELLA®. The primary endpoint was 30-day all-cause death. VA-ECMO patients were younger (52 vs. 59.4, p = 0.006) and had a higher lactate level at baseline than those in the IMPELLA® group (6.84 vs. 3.03 mmol/L, p <, 0.001). Duration of MCS was similar between groups (9.4 days vs. 6 days in the VA-ECMO and IMPELLA® groups respectively, p = 0.077). In unadjusted analysis, no significant difference was observed between groups in 30-day mortality: 43.3% vs. 58.1% in the VA-ECMO and IMPELLA® groups, respectively (p = 0.152). After adjustment, VA-ECMO was associated with a significant reduction in 30-day mortality (HR = 0.25, p = 0.004). A higher rate of MCS escalation was observed in the IMPELLA® group: 32.3% vs. 10.3% (p = 0.003). In patients eligible to either VA-ECMO or IMPELLA® for LV dominant refractory CS, VA-ECMO was associated with improved survival rate and a lower need for escalation.
- Published
- 2021
36. Percutaneous venopulmonary artery extracorporeal membrane oxygenation for right heart failure after left ventricular assist device insertion
- Author
-
Alain Bel, Jean-Michel Grinda, Nadia Aissaoui, Christian Latremouille, Marie-Cécile Bories, Yashutosh Joshi, and Jérôme Jouan
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Femoral vein ,030204 cardiovascular system & hematology ,Pulmonary Artery ,03 medical and health sciences ,0302 clinical medicine ,Extracorporeal Membrane Oxygenation ,medicine ,Extracorporeal membrane oxygenation ,Humans ,Retrospective Studies ,Heart Failure ,business.industry ,Extracorporeal Technologies ,Left pulmonary artery ,medicine.disease ,Cannula ,Mediastinitis ,Surgery ,surgical procedures, operative ,030228 respiratory system ,Ventricular assist device ,Heart-Assist Devices ,Cardiology and Cardiovascular Medicine ,business ,Destination therapy - Abstract
OBJECTIVES Right ventricular failure after left ventricular assist device (LVAD) insertion is associated with significant mortality and morbidity. Mechanical support options include right ventricular assist devices, venoarterial extracorporeal membrane oxygenation (ECMO) and venopulmonary artery ECMO, the latter often involving central cannulation. We sought to evaluate the feasibility and early outcomes of a truly percutaneous venopulmonary artery (pVPA) ECMO strategy, with the potential advantage of bedside removal once weaned. METHODS Data from a single tertiary centre were reviewed retrospectively from January 2014 to January 2019. During this time, 54 patients underwent LVAD insertion, with 19 requiring mechanical support for right ventricular failure. Among them, 10 patients received pVPA ECMO. Implantation of the pVPA ECMO was performed under transoesophageal echocardiography and fluoroscopy guidance, with an inflow cannula placed in the right atrium via the right femoral vein and an outflow cannula placed in the left pulmonary artery (PA) via the right internal jugular vein. RESULTS Cannula insertion was 100% successful with no need for repositioning. Eight patients (80%) were able to be successfully weaned (at the bedside); 6 were discharged from the hospital and there were no cases of early sepsis, mediastinitis or thromboembolism. At follow-up, 5 patients had received transplants (50%), with 1 on LVAD support as destination therapy (10%). Survival was 60 ± 15% and 50 ± 16% at 6 and 12 months, respectively. CONCLUSIONS pVPA ECMO is 100% technically feasible and is an efficient method for temporary right ventricular support after LVAD insertion with the advantage of simple bedside removal and avoidance of a PA graft remnant in the chest cavity.
- Published
- 2021
37. Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop
- Author
-
Antoni Bayes-Genis, Uwe Zeymer, Alexandre Mebazaa, Janine Pöss, Susanna Price, Bruno François, Bruno Levy, M. Karakas, Michael O. Harhay, Navin K. Kapur, Maciej Kostrubiec, Pascal Leprince, Martine Gilard, Yves Rosenberg, Nadia Aissaoui, Etienne Gayat, Mattia Arrigo, David A. Baran, Laurent Bonello, and Holger Thiele
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Critical Care ,business.industry ,Cardiogenic shock ,Myocardial Infarction ,Shock, Cardiogenic ,Psychological intervention ,MEDLINE ,Context (language use) ,medicine.disease ,Clinical trial ,Multidisciplinary approach ,medicine ,Humans ,Position paper ,Myocardial infarction ,Intensive care medicine ,business - Abstract
Acute myocardial infarction complicated by cardiogenic shock (AMICS) is a critical syndrome with a high risk of morbidity and mortality. Current management consists of coronary revascularisation, vasoactive drugs, and circulatory and ventilatory support, which are tailored to patients mainly on the basis of clinicians' experience rather than evidence-based recommendations. For many therapeutic interventions in AMICS, randomised clinical trials have not shown a meaningful survival benefit, and a disproportionately high rate of neutral and negative results has been reported. In this context, an accurate definition of the AMICS syndrome for appropriate patient selection and optimisation of study design are warranted to achieve meaningful results and pave the way for new, evidence-based therapeutic options. In this Position Paper, we provide a statement of priorities and recommendations agreed by a multidisciplinary group of experts at the Critical Care Clinical Trialists Workshop in February, 2020, for the optimisation and harmonisation of clinical trials in AMICS. Implementation of proposed criteria to define the AMICS population-moving beyond a cardio-centric definition to that of a systemic disease-and steps to improve the design of clinical trials could lead to improved outcomes for patients with this life-threatening syndrome.
- Published
- 2021
38. The Surgical Management of a Giant Innominate Artery Aneurysm in a Patient With Coronary Disease: A Case Report
- Author
-
Nabila Ismaili, Ramia Bougrine, Hanane Aissaoui, Ihsane Alloubi, and Noha Elouafi
- Subjects
Spontaneous rupture ,medicine.medical_specialty ,Bypass grafting ,Cardiology ,innominate artery aneurysm ,030204 cardiovascular system & hematology ,Coronary disease ,Coronary artery disease ,03 medical and health sciences ,High morbidity ,0302 clinical medicine ,Anesthesiology ,Medicine ,Surgical repair ,Artery aneurysm ,business.industry ,Mortality rate ,General Engineering ,food and beverages ,medicine.disease ,Surgery ,coronary artery bypass ,coronaropathy ,Cardiac/Thoracic/Vascular Surgery ,business ,030217 neurology & neurosurgery - Abstract
The innominate artery aneurysm (IAA) accounts for a small percentage of all peripheral aneurysms. However, its clinical outcomes are potentially devastating, especially when it is associated with coronary disease, due to the high risk of spontaneous rupture and thromboembolic complications. Surgical repair is always recommended in such cases. The treatment of such a condition presents a surgical challenge with high morbidity and mortality rates. In this report, we discuss the case of a 56-year-old male who presented with a right cervical mass secondary to a large IAA with underlying coronary artery disease. The patient underwent a simultaneous operation for IAA and coronary bypass grafting.
- Published
- 2021
39. Identifying Clinical Phenotypes in Moderate to Severe Acute Respiratory Distress Syndrome Related to COVID-19: The COVADIS Study
- Author
-
Jean-Baptiste Lascarrou, Aurelie Gaultier, Thibaud Soumagne, Nicolas Serck, Bertrand Sauneuf, Michael Piagnerelli, Andre Ly, Francois Lejeune, Laurent Lefebvre, Sami Hraiech, Geoffrey Horlait, Julien Higny, Alain D'hondt, Stephane Gaudry, Romain Courcelle, Giuseppe Carbutti, Gauthier Blonz, Gregoire Ottavy, Nadia Aissaoui, Christophe Vinsonneau, Benoit Vandenbunder, Julien Textoris, Piotr Szychowiak, David Grimaldi, the COVADIS study group, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Services des soins intensifs, UCL - (MGD) Service de cardiologie, Anesthésiologie et Réanimation [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Plateforme de Méthodologie et Biostatistique, Direction de la Recherche [CHU Nantes], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Saint Pierre clinic of Ottignies (CSPO), Saint Pierre clinic of Ottignies, CH Centre Hospitalier Public du Cotentin (CHPC), Université libre de Bruxelles (ULB), Hôpital Henri Mondor, Centre Hospitalier d'Aix en Provence [Aix-en-Provence] (CHIAP ), Centre d'études et de recherche sur les services de santé et la qualité de vie (CEReSS), Aix Marseille Université (AMU), Hôpital Nord [CHU - APHM], CHU Dinant-Godinne UCL Namur [Yvoir, Belgique], CHU Ambroise Paré [Mons, Belgium], Université Sorbonne Paris Nord, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hopital de Jolimont, hospital universitaire de Mons-Hainaut, Centre Hospitalier Départemental site de la Roche-sur-Yon (CHD de la Roche-sur-Yon), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre Hospitalier de Béthune (CH Béthune), GHT de l'Artois, Hôpital Privé d'Antony, Hospices Civils de Lyon (HCL), BIOMERIEUX, CRICS-TRIGGERSEP, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d’Investigation Clinique [Tours] CIC 1415 (CIC ), and Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
medicine.medical_specialty ,ARDS ,phenotype ,Fulminant ,Disease ,mechanical ventilation ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,intubation ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Intensive care ,Internal medicine ,Diabetes mellitus ,Medicine ,Original Research ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,lcsh:R5-920 ,business.industry ,Acute kidney injury ,COVID-19 ,Généralités ,General Medicine ,medicine.disease ,Pulmonary embolism ,Venous thrombosis ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,lcsh:Medicine (General) - Abstract
Objectives: Different phenotypes have been identified in acute respiratory distress syndrome (ARDS). Existence of several phenotypes in coronavirus disease (COVID-19) related acute respiratory distress syndrome is unknown. We sought to identify different phenotypes of patients with moderate to severe ARDS related to COVID-19. Methods: We conducted an observational study of 416 COVID-19 patients with moderate to severe ARDS at 21 intensive care units in Belgium and France. The primary outcome was day-28 ventilatory free days. Secondary outcomes were mortality on day 28, acute kidney injury, acute cardiac injury, pulmonary embolism, and deep venous thrombosis. Multiple factor analysis and hierarchical classification on principal components were performed to distinguish different clinical phenotypes. Results: We identified three different phenotypes in 150, 176, and 90 patients, respectively. Phenotype 3 was characterized by short evolution, severe hypoxemia, and old comorbid patients. Phenotype 1 was mainly characterized by the absence of comorbidities, relatively high compliance, and long duration of symptoms, whereas phenotype 2 was characterized female sex, and the presence of mild comorbidities such as uncomplicated diabetes or chronic hypertension. The compliance in phenotype 2 was lower than that in phenotype 1, with higher plateau and driving pressure. Phenotype 3 was associated with higher mortality compared to phenotypes 1 and 2. Conclusions: In COVID-19 patients with moderate to severe ARDS, we identified three clinical phenotypes. One of these included older people with comorbidities who had a fulminant course of disease with poor prognosis. Requirement of different treatments and ventilatory strategies for each phenotype needs further investigation., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2021
40. Acute Coronary Artery Thrombosis in a Patient With Non-Small Cell Lung Cancer
- Author
-
Noha Elouafi, Hanane Aissaoui, Ismahane Lahmidi, and Nabila Ismaili
- Subjects
Acute coronary syndrome ,medicine.medical_specialty ,pulmonary embolism ,Pulmonology ,Cardiology ,acute myocardial infarction ,030204 cardiovascular system & hematology ,Chest pain ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine.artery ,medicine ,Pulmonary angiography ,Myocardial infarction ,cardiovascular diseases ,Stroke ,business.industry ,cancer-associated thrombosis ,General Engineering ,medicine.disease ,Thrombosis ,Pulmonary embolism ,Oncology ,Right coronary artery ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Patients with cancer are at major risk for both venous and arterial thrombotic complications. Venous involvement of cancer-associated thrombosis encompasses deep vein thrombosis and pulmonary embolism. Arterial manifestations include mainly stroke and myocardial infarction. We present the case of a 59-year-old woman admitted to the hospital for chest pain of five hours duration. She had been diagnosed with advanced lung cancer one month before. Electrocardiogram showed ST-segment elevation in all leads except aVR, suggesting a myocardial infarction. Coronary angiography revealed thrombi in both the right coronary artery and the left anterior descending coronary artery in the absence of any atherosclerotic lesions. Tirofiban infusion was administered; furthermore, a computed tomographic pulmonary angiography showed a distal pulmonary embolism. The patient progressed well and was discharged on anticoagulation with vitamin K antagonist. These findings highly imply that the malignancy altered the patient's blood coagulability and induced the formation of the thrombi ensuing acute myocardial infarction and pulmonary embolism. We will emphasize the relationship between cancer and thrombosis with a special focus on the conservative management strategy with anticoagulant and antiplatelet therapy in acute coronary syndrome without evidence of atherosclerotic lesions.
- Published
- 2021
41. Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM Excellence Center Study
- Author
-
Samia Hamane, Blandine Denis, Sanja Pleško, Nesrine Aissaoui, Juergen Prattes, Ivana Mareković, Stéphane Bretagne, Maud Gits-Muselli, Jörg Steinmann, Alexandre Alanio, Johan Maertens, Katrien Lagrou, Toine Mercier, Ulrike Scharmann, and Harald H. Kessler
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Medizin ,Plant Science ,Gastroenterology ,Article ,Pneumocystis jirovecii ,03 medical and health sciences ,0302 clinical medicine ,non-HIV patient ,Internal medicine ,qPCR ,broncho-alveolar lavage fluid ,fungal load ,biomarker ,(1, 3)-β-d-glucan ,medicine ,Pneumocystosis ,In patient ,030212 general & internal medicine ,Respiratory system ,lcsh:QH301-705.5 ,Ecology, Evolution, Behavior and Systematics ,0303 health sciences ,biology ,medicine.diagnostic_test ,(1,3)-β-d-glucan ,030306 microbiology ,business.industry ,biology.organism_classification ,medicine.disease ,respiratory tract diseases ,Real-time polymerase chain reaction ,Bronchoalveolar lavage ,lcsh:Biology (General) ,Biomarker (medicine) ,business ,1 3 β d glucan ,d<%2Fspan>-glucan%22">(1,3)-β-d-glucan - Abstract
Pneumocystis jirovecii pneumonia is a difficult invasive infection to diagnose. Apart from microscopy of respiratory specimens, two diagnostic tests are increasingly used including real-time quantitative PCR (qPCR) of respiratory specimens, mainly in bronchoalveolar lavage fluids (BAL), and serum &beta, 1,3-d-glucan (BDG). It is still unclear how these two biomarkers can be used and interpreted in various patient populations. Here we analyzed retrospectively and multicentrically the correlation between BAL qPCR and serum BDG in various patient population, including mainly non-HIV patients. It appeared that a good correlation can be obtained in HIV patients and solid organ transplant recipients but no correlation can be observed in patients with hematologic malignancies, solid cancer, and systemic diseases. This observation reinforces recent data suggesting that BDG is not the best marker of PCP in non-HIV patients, with potential false positives due to other IFI or bacterial infections and false-negatives due to low fungal load and low BDG release.
- Published
- 2020
- Full Text
- View/download PDF
42. Characteristics, mortality and prognostic factors of acute right ventricular myocardial infarction: A case-control study
- Author
-
Karim Wahbi, Nadia Aissaoui, Christophe Meune, Aures Chaib, C. Sleiman, E. Sorbets, M. El Aissaoui, and S. Weber
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Cardiogenic shock ,Mortality rate ,Case-control study ,030204 cardiovascular system & hematology ,After discharge ,medicine.disease ,Revascularization ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Angioplasty ,medicine ,Cardiology ,Observational study ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Right Ventricular (RV) involvement during inferior acute myocardial infarction (AMI) was known to be associated with poor outcome, but might have been mitigated by recent therapeutics. The aim of study was to determine the characteristics and outcomes of patients with RVAMI compared to isolated inferior AMI. Methods This is an observational study that enrolled consecutive patients with RVAMI; age-sex matched patients with isolated inferior AMI served as controls. Results A total of 51 patients with RVAMI were studied (male 39, age 63 ± 16) and compared to 39 age-sex matched patients with isolated inferior AMI. Atherosclerosis risk factors, previous MI and treatment at presentation were similar in both groups. Primary coronary angioplasty was successful in > 90% in both groups. When compared to patients with isolated inferior AMI, patients with RVAMI had more frequent cardiogenic shock at presentation (35% versus 0%, P P Conclusion RVAMI is still associated with high in-hospital mortality. The severity of initial presentation is not a prognostic factor. Mortality rates after discharge increased very slowly and similarly in both groups.
- Published
- 2017
43. PO-1120 skin toxicity of hypofractionated vs conventional irradiation after mastectomy for breast cancer
- Author
-
M. el bessi, A. Hamdoun, J. Yahyaoui, N. nsiri, R. Ben Amor, Lotfi Kochbati, D. Aissaoui, and M. Bohli
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Hematology ,medicine.disease ,Breast cancer ,Skin toxicity ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Irradiation ,business ,Mastectomy - Published
- 2021
44. Efficiency Analysis to evaluate a Breast Cancer Screening Campaign: A Case Study from Tunisia
- Author
-
Nadra Bohli, Safa Bhar Layeb, Chokri Hamouda, Zied Jemai, Nouha Ben Fatma, Najla Omrane Aissaoui, Mohamed Amine Frikha, Laboratoire Génie Industriel - EA 2606 (LGI), and CentraleSupélec
- Subjects
Future studies ,medicine.diagnostic_test ,business.industry ,Multidisciplinary study ,medicine.disease ,Breast cancer screening ,Market research ,Breast cancer ,Environmental health ,Data envelopment analysis ,Screening programs ,[SHS.GESTION]Humanities and Social Sciences/Business administration ,Medicine ,business ,ComputingMilieux_MISCELLANEOUS - Abstract
Despite the tremendous clinical advances, breast cancer remains one of the deadliest cancers for women around the world. This has led to a wide variety of awareness and screening programs in several countries, with often questioned real impacts. In this perspective, this multidisciplinary study was conducted to evaluate the effectiveness of the Tunisian national breast cancer screening campaign in 2019. The Data Envelopment Analysis (DEA) approach was used to measure the relative effectiveness of the governorates with respect to this campaign. Preliminary numerical experimentation reveals promising results and highlights venues for future studies.
- Published
- 2020
45. Prothrombotic disorders in non-cirrhotic, non-tumoral portal vein thrombosis
- Author
-
Hassane Mamad, P L Nahm-Tchougli Christiana, Azlarab Masrar, Zakia Berchane, Yousra El Aissaoui, and Souad Benkirane
- Subjects
Liver Cirrhosis ,Venous Thrombosis ,medicine.medical_specialty ,business.industry ,Portal Vein ,Hematology ,Budd-Chiari Syndrome ,medicine.disease ,Thrombophilia ,Gastroenterology ,Portal vein thrombosis ,Internal medicine ,medicine ,Humans ,business - Published
- 2020
46. Impact of late administration of corticosteroids in COVID-19 ARDS
- Author
-
Mongardon, N., Piagnerelli, Michaël, Grimaldi, David, Perrot, Bastien, Lascarrou, Jean Baptiste, Aissaoui, Nadia, Blonz, Gauthier, Carbutti, Giuseppe, Courcelle, Romain, Gaudry, Stéphane, D’hondt, Alain, Higny, Julien, Horlait, Geoffrey, Hraiech, Sami, Lefebvre, Laurent, Lejeune, François Xavier, Ly, André, Pletschette, Zoé, Sauneuf, Bertrand, Serck, Nicolas, Soumagne, Thibaud, Szychowiak, Piotr, Textoris, Julien, Vandenbunder, Benoit, Vinsonneau, Christophe, UCL - SSS/IREC/MONT - Pôle Mont Godinne, and UCL - (MGD) Services des soins intensifs
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,ARDS ,Letter ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Time to treatment ,Critical Care and Intensive Care Medicine ,Methylprednisolone ,Drug Administration Schedule ,Time-to-Treatment ,Adrenal Cortex Hormones ,Anesthesiology ,medicine ,Humans ,Proportional Hazards Models ,Respiratory Distress Syndrome ,Dose-Response Relationship, Drug ,business.industry ,COVID-19 ,Généralités ,Confounding Factors, Epidemiologic ,medicine.disease ,COVID-19 Drug Treatment ,Multicenter study ,Anesthesia ,business ,Administration (government) - Abstract
SCOPUS: le.j, info:eu-repo/semantics/published
- Published
- 2020
47. Physiological effects of adding ECCO2R to invasive mechanical ventilation for COPD exacerbations
- Author
-
A. Arnoux, Emmanuel Guerot, Jean Luc Diehl, Nadia Aissaoui, Christian Richard, D. Hourton, Jean Loup Augy, Marc Pierrot, Alain Mercat, Jordi Mancebo, Lise Piquilloud, Damien Vimpere, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Institut de biologie et chimie des protéines [Lyon] (IBCP), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), Université de Technologie de Belfort-Montbeliard (UTBM)-Université de Bourgogne (UB)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS), Institut d'Électronique et des Technologies du numéRique (IETR), Université de Nantes (UN)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-CentraleSupélec-Centre National de la Recherche Scientifique (CNRS), University of Tampere [Finland], Innovations thérapeutiques en hémostase (IThEM - U1140), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Université de Lausanne = University of Lausanne (UNIL), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Hôpital Bicêtre, Hospital de la Santa Creu i Sant Pau, and GUENEGOU ARNOUX, Armelle
- Subjects
medicine.medical_specialty ,[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT] ,Respiratory rate ,Exacerbation ,medicine.medical_treatment ,Alveolar ventilation ,COPD acute exacerbation ,Extracorporeal carbon dioxide removal ,Invasive mechanical ventilation ,Work of breathing ,Critical Care and Intensive Care Medicine ,Extracorporeal ,03 medical and health sciences ,0302 clinical medicine ,Functional residual capacity ,Internal medicine ,medicine ,Dynamic hyperinflation ,Mechanical ventilation ,COPD ,business.industry ,[SDV.OT] Life Sciences [q-bio]/Other [q-bio.OT] ,Research ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,030208 emergency & critical care medicine ,lcsh:RC86-88.9 ,medicine.disease ,030228 respiratory system ,Cardiology ,business - Abstract
Background Extracorporeal CO2 removal (ECCO2R) could be a valuable additional modality for invasive mechanical ventilation (IMV) in COPD patients suffering from severe acute exacerbation (AE). We aimed to evaluate in such patients the effects of a low-to-middle extracorporeal blood flow device on both gas exchanges and dynamic hyperinflation, as well as on work of breathing (WOB) during the IMV weaning process. Study design and methods Open prospective interventional study in 12 deeply sedated IMV AE-COPD patients studied before and after ECCO2R initiation. Gas exchange and dynamic hyperinflation were compared after stabilization without and with ECCO2R (Hemolung, Alung, Pittsburgh, USA) combined with a specific adjustment algorithm of the respiratory rate (RR) designed to improve arterial pH. When possible, WOB with and without ECCO2R was measured at the end of the weaning process. Due to study size, results are expressed as median (IQR) and a non-parametric approach was adopted. Results An improvement in PaCO2, from 68 (63; 76) to 49 (46; 55) mmHg, p = 0.0005, and in pH, from 7.25 (7.23; 7.29) to 7.35 (7.32; 7.40), p = 0.0005, was observed after ECCO2R initiation and adjustment of respiratory rate, while intrinsic PEEP and Functional Residual Capacity remained unchanged, from 9.0 (7.0; 10.0) to 8.0 (5.0; 9.0) cmH2O and from 3604 (2631; 4850) to 3338 (2633; 4848) mL, p = 0.1191 and p = 0.3013, respectively. WOB measurements were possible in 5 patients, indicating near-significant higher values after stopping ECCO2R: 11.7 (7.5; 15.0) versus 22.6 (13.9; 34.7) Joules/min., p = 0.0625 and 1.1 (0.8; 1.4) versus 1.5 (0.9; 2.8) Joules/L, p = 0.0625. Three patients died in-ICU. Other patients were successfully hospital-discharged. Conclusions Using a formalized protocol of RR adjustment, ECCO2R permitted to effectively improve pH and diminish PaCO2 at the early phase of IMV in 12 AE-COPD patients, but not to diminish dynamic hyperinflation in the whole group. A trend toward a decrease in WOB was also observed during the weaning process. Trial registration ClinicalTrials.gov: Identifier: NCT02586948.
- Published
- 2020
48. Symmetrical and Peripheral Gangrene Complicating a Third-Degree Atrioventricular Block: A New Presentation of a Known Disease
- Author
-
Karima Benbouchta, Hanane Aissaoui, Brahim Housni, Noha Elouafi, and Nabila Ismaili
- Subjects
medicine.medical_specialty ,Cardiac output ,business.industry ,PERIPHERAL GANGRENE ,Third-degree atrioventricular block ,Vessel occlusion ,General Engineering ,Cardiology ,symmetrical and peripheral gangrene ,low cardiac flow ,Disease ,Dermatology ,030204 cardiovascular system & hematology ,medicine.disease ,third degree atrioventricular block ,03 medical and health sciences ,0302 clinical medicine ,Anesthesiology ,Internal medicine ,medicine ,case report ,Presentation (obstetrics) ,business ,030217 neurology & neurosurgery - Abstract
Symmetrical peripheral gangrene (SPG) is a rare, serious entity characterized by ischemic changes of the distal extremities with no vessel occlusion, leading to fatal complications. It is related to numerous causes, and the treatment is not yet consensual. We present the first case of SPG related to low cardiac output secondary to a third-degree atrioventricular block. Physicians should be aware of this entity, as early recognition and adequate management can help in reducing morbidity and mortality and prevent fatal complications.
- Published
- 2020
49. Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit
- Author
-
Mohamed Benghanem Gharbi, Chafik El Kettani El Hamidi, Hanane Ezzouine, Kamal Marhoum El Filali, Maha Soussi Abdallaoui, Naima El Mdaghri, Ouissal Aissaoui, Boubaker Charra, Siham El Aziz, Nassim Essabah Haraj, Rachid Al Harrar, Asma Chadli, Afak Nsiri, Benyounes Ramdani, Nisrine El Kebbaj, Asma Dafir, Nabiha Kamal, L. Barrou, Ghali Mohamed Bennouna, Moulay Hicham Afif, and Amal Mjabber
- Subjects
0301 basic medicine ,Male ,Pediatrics ,Endocrinology, Diabetes and Metabolism ,Overweight ,law.invention ,Body Mass Index ,0302 clinical medicine ,law ,Weight loss ,Prevalence ,Medicine ,Hypoalbuminemia ,Nutrition and Dietetics ,Rehabilitation ,Middle Aged ,Intensive care unit ,Patient Discharge ,Intensive Care Units ,Original Article ,Female ,medicine.symptom ,Adult ,medicine.medical_specialty ,Critical Care ,Anemia ,Nutritional Status ,030209 endocrinology & metabolism ,03 medical and health sciences ,Intensive care ,Lymphopenia ,Weight Loss ,Humans ,Pandemics ,Aged ,030109 nutrition & dietetics ,business.industry ,SARS-CoV-2 ,Malnutrition ,COVID-19 ,Nutrients ,Length of Stay ,medicine.disease ,Diet ,Nutrition Assessment ,business ,Deficiency Diseases ,Body mass index - Abstract
Summary Introduction The nutritional diagnosis and early nutritional management of COVID-19 patients must be integrated into the overall therapeutic strategy. The aim of our study is to assess the nutritional status of patients with COVID-19 after a stay in intensive care, to describe the prevalence of undernutrition, to determine the factors influencing undernutrition and to describe the nutritional management. Tools and methods This is a descriptive observational study of adult patients admitted to the endocrinology service for additional care after a stay in intensive care during the period from April 17, 2020 to May 26, 2020. The assessment tool used was the Mini Nutritional Assessment (MNA). Results Our study included 41 patients; the average age of the patients was 55 years, 51.2% had a severe or critical form of COVID-19, 75.6% stayed in intensive care, 12.2% had a loss of autonomy. The average BMI was 25.2 kg/m2 (17–42 kg/m2), 42.5% were overweight, 61% had weight loss, 26.2% had weight loss greater than 10%, 14.6% of our patients were undernourished, 65.9% were at risk of undernutrition, 19.5% had hypoalbuminemia, 17.1% had hypoprotidemia, 19.5% hypocalcemia, 34.1% anemia, 12.2% hypomagnesemia and 51.2% had a deficiency in vitamin D. A positive correlation was found between poor nutritional status and a longer stay in intensive care (>5 days) (p = 0.011) and lymphopenia (p = 0,02). Conclusion Despite a personalized diet, 14.6% of patients presented undernutrition. Particular attention should be paid to patients with a long stay in intensive care.
- Published
- 2020
50. New Markers of Bone Fragility in Hemodialysis Patients: A Monocentric Study
- Author
-
Afef Bahlous, Maroua Slouma, Takoua Aissaoui, Fatma Ben Moussa, Mohamed Elleuch, Lilia Laadhar, Imen Gharsallah, Hela Sahli, W. Smaoui, Maissa Abbes, and Elhem Cheour
- Subjects
0301 basic medicine ,Fibroblast growth factor 23 ,Adult ,Male ,medicine.medical_specialty ,animal structures ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Osteoporosis ,Urology ,030209 endocrinology & metabolism ,Bone fragility ,complex mixtures ,Collagen Type I ,03 medical and health sciences ,0302 clinical medicine ,Fragility ,N-terminal telopeptide ,Bone Density ,Renal Dialysis ,polycyclic compounds ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Orthopedics and Sports Medicine ,Dialysis ,Aged ,Receiver operating characteristic ,business.industry ,Middle Aged ,medicine.disease ,Alkaline Phosphatase ,Fibroblast Growth Factors ,Bone Diseases, Metabolic ,Fibroblast Growth Factor-23 ,Cross-Sectional Studies ,Female ,030101 anatomy & morphology ,Hemodialysis ,business ,Peptides ,Biomarkers - Abstract
Introduction: Mechanisms underlying bone fragility in patients under dialysis are various. The assessment of bone disorder is not yet codified in these patients. Our study aimed to determine the relationship between the serum fibroblast growth factor 23 (FGF23) level and bone fragility. We also aimed to assess the bone alkaline phosphatase (bAP) to the C-terminal telopeptide of type I (CTX) ratio and the FGF23*bAP product to CTX ratio in patients under hemodialysis. Methodology: We conducted a cross-sectional study, including 76 patients under hemodialysis. To assess bone fragility, we measured bAP, CTX, and FGF 23. We calculated the bAP to the CTX ratio (bAP/CTX) and the FGF23*bAP product to the CTX ratio (FGF23*bAP/CTX). We defined bone fragility as the existence of osteoporosis or fragility fractures. Receiver operating characteristic (ROC) curves were evaluated for each biological using the existence of osteoporosis or fragility fracture as the gold standard for bone fragility. Results: There were 51 men. The mean age was 53.36 ± 14.27 years. Bone fragility was noted in 25 cases. Patients with osteoporosis had higher FGF*bAP/CTX and bAP/CTX ratios. The ability of the ratio (bAP/CTX) to distinguish patients with osteoporosis from those without osteoporosis was good, with a ROC AUC of 0.707. The optimal ratio cut-off value with the highest accuracy was 9.72. The ability of the ratio (FGF23*bAP/CTX) to distinguish patients with bone fragility was good, with a ROC AUC of 0.701. The optimal ratio cut-off value with the highest accuracy was 1621.89 (sensitivity 60%, specificity 78.4%). Conclusion: Our study showed FGF23, FGF23*bAP product to CTX ratio, and the bAP to CTX ratio can be used as markers of bone fragility in hemodialysis patients. Therefore, these noninvasive and relatively inexpensive methods may serve to diagnose bone fragility in patients under hemodialysis.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.